{
  "meta": {
    "title": "Medicine_Test_-_2",
    "url": "https://brainandscalpel.vercel.app/medicine-test-2-ce39d28c.html",
    "scrapedAt": "2025-11-30T12:48:41.194Z"
  },
  "questions": [
    {
      "text": "A patient presents with right lower abdominal pain and loose stools for the past 8 months. He smokes 12 cigarettes per day for the last 10 years. Endoscopy findings are shown below. Identify the correct statement about this condition. ",
      "choices": [
        {
          "id": 1,
          "text": "Granulomas are seen in the lymph nodes"
        },
        {
          "id": 2,
          "text": "Lesions extend upto the rectum"
        },
        {
          "id": 3,
          "text": "Lesions are present in a continuous pattern"
        },
        {
          "id": 4,
          "text": "Inflammation is limited to mucosa and submucosa"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features of loose stools, right lower quadrant pain, and endoscopy showing <strong>cobblestone appearance</strong>,<strong> </strong>with a history of smoking suggest a diagnosis of <strong>Crohn's disease </strong>(CD). In this condition, <strong>granulomas</strong> can be seen in the layers of the small bowel, lymph nodes, mesentery, peritoneum, liver, and pancreas.</p>\n<p>Microscopically, they are <strong>non-caseating granulomas</strong>. Other histologic features of CD include submucosal or subserosal lymphoid aggregates, microscopic skip areas, transmural inflammation, etc.</p>\n<p>The inflammation in Crohn's disease mainly affects the <strong>ileum</strong> and <strong>colon</strong>,<strong> </strong>while the <strong>rectum</strong> is often<strong> spared. </strong>The earliest lesions seen are aphthous ulcers located in the mucosa which then spreads to result in <strong>transmural inflammation</strong>. There is normal mucosa in between the ulcers (<strong>skip lesions</strong>) which gives them a <strong>cobblestone appearance</strong> seen on microscopy. Another finding is the growth of mesenteric fat leading to extensive fat wrapping around the bowel wall which is termed as <strong>creeping fat</strong>. In addition, Crohn's disease often have adhesions and fistulas.</p>\n<p>Other options:</p>\n<p>In <strong>ulcerative colitis</strong>, lesions begin from the <strong>dentate line </strong>(rectum) and <strong>extend</strong> <strong>proximally</strong>. They are<strong> continuous lesions</strong>. Histologically, the lesions and inflammation are within the <strong>lamina propria</strong> and <strong>limited</strong> to the <strong>surface epithelium</strong>. </p><hr><h3>Related Pearl: Inflammatory Bowel Disease (IBD)</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset </strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades </td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td> None </td>\n<td>\n<p>Smoking </p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life </p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1 </td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement </p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps </p>\n<p>Backwash ileitis </p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings </strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia  </p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications </strong></td>\n<td>\n<p>Fistulas </p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings </strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis </p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fe8d2de957804475ac4979e2c93b73fa.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9471",
      "difficulty": "medium"
    },
    {
      "text": "A young man presented with a growing mass in the neck. It was found to be medullary thyroid carcinoma after workup. Further investigations revealed the presence of pheochromocytoma and parathyroid adenoma. He mentions that his uncle and his grandfather also had some form of cancer. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Multiple endocrine neoplasia 2A"
        },
        {
          "id": 2,
          "text": "Multiple endocrine neoplasia 2B"
        },
        {
          "id": 3,
          "text": "Multiple endocrine neoplasia 1"
        },
        {
          "id": 4,
          "text": "Multiple endocrine neoplasia 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The patient has medullary thyroid cancer, along with pheochromocytoma and parathyroid adenoma. He is likely to be suffering from <strong>multiple endocrine neoplasia (MEN) 2A.</strong></p>\n<p>Multiple endocrine neoplasia is characterized by the presence of tumors in <strong>two </strong>or<strong> more endocrine glands.&nbsp;</strong>It can be MEN 1, MEN 2A, MEN 2B (MEN 3), or MEN 4.</p>\n<p>MEN <strong>1</strong> is associated mainly with <strong>parathyroid adenoma, pancreatic tumors,</strong> and<strong> pituitary tumors.&nbsp;</strong></p>\n<p>MEN<strong> 2A</strong> is associated mainly with medullary thyroid carcinoma, pheochromocytoma, and <strong>parathyroid adenoma.&nbsp;</strong></p>\n<p>MEN<strong> 2B</strong>&nbsp;is associated mainly with medullary thyroid carcinoma, pheochromocytoma, <strong>mucosal neuroma, marfanoid habitus</strong>, medullated corneal nerve fibers, and megacolon.</p>\n<p>MEN <strong>4</strong> is associated with parathyroid adenoma, pituitary adenoma, and <strong>reproductive organ tumors.</strong></p><hr><h3>Related Pearl: MEN 1 Syndrome Features</h3><p>Chromosome <strong>11q13 / MEN1 </strong>gene</p>\n<p>Also known as <strong>Wermer&rsquo;s syndrome</strong></p>\n<p>Characteristic tumors seen in:</p>\n<ul>\n<li>Parathyroid adenoma &ndash; 90 % - Most common overall</li>\n<li>Entero pancreatic tumors - Most common functioning tumor is gastrinoma (most common site is duodenum)</li>\n<li>Pituitary adenoma &ndash; Most common is prolactinoma</li>\n<li><strong>Mnemonic</strong> &ndash; Par Pan Pit &ndash; in decreasing order of frequency</li>\n</ul>\n<p>Associated tumors are:</p>\n<ul>\n<li>Angiofibroma</li>\n<li>Collagenomas</li>\n<li>Adrenal cortical tumors</li>\n<li>Lipoma</li>\n<li>Neuroendocrine tumors - gastric, thymic, lungs</li>\n<li>Meningioma</li>\n<li>Pheochromocytoma</li>\n<li>Carcinoid tumors, usually of the foregut</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95f7c4eac7794f728806926c4f50bbb2x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 4 Syndrome Features</h3><p>It is associated with CDKN1B gene on&nbsp;chromosome 12.</p>\n<p>Associated conditions:</p>\n<ul>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Reproductive organ tumors like testicular cancer, neuroendocrine cervical carcinoma</li>\n<li>Adrenal and renal tumors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9451",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is incorrect regarding subacute thyroiditis?",
      "choices": [
        {
          "id": 1,
          "text": "Thyrotoxic phase is followed by hypothyroid phase"
        },
        {
          "id": 2,
          "text": "Painful condition"
        },
        {
          "id": 3,
          "text": "Preceded by upper respiratory tract infection"
        },
        {
          "id": 4,
          "text": "Antithyroid drugs are given in the thyrotoxic phase of the disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Antithyroid drugs have no role in the management of the thyrotoxic phase of subacute thyroiditis.&nbsp;</p>\n<p>Subacute thyroiditis is a granulomatous thyroiditis that occurs <strong>secondary to viral upper respiratory tract infections</strong>. Many viruses such as <strong>mumps, influenza, coxsackie, adenoviruses, </strong>and<strong> echoviruses</strong> have been implicated in this condition. This condition is predominantly seen in middle-aged women, and usually resolves without any sequelae.</p>\n<p>Patients present with <strong>painfully enlarged thyroid</strong> gland and <strong>fever</strong>. Depending on the phase of the illness, it may present with <strong>features of thyrotoxicosis or hypothyroidism</strong>. The natural history of the disease has <strong>three phases</strong>:</p>\n<ul>\n<li><strong>Thyrotoxic phase:</strong>&nbsp;there is increased follicular destruction and release of thyroglobulin and thyroid hormones, leading to increased circulating T<span class=\"s1\">4 </span>and T<span class=\"s1\">3 </span>and suppression of TSH</li>\n<li><strong>Hypothyroid phase:</strong> after some days the thyroid hormone stores are depleted leading to hypothyroidism. This phase is characterized has low free T<span class=\"s1\">4 </span>(and sometimes T<span class=\"s1\">3</span>) and moderately increased TSH levels.</li>\n<li><strong>Recovery phase: </strong>The thyroid hormones and TSH come to normal levels as the patient completely recovers from the disease.</li>\n</ul>\n<p>Subacute thyroiditis is <strong>treated with</strong> large doses of <strong>aspirin or NSAIDs.&nbsp;</strong>If there are severe local or systemic systems, then <strong>steroids</strong> are used.<strong> Beta-blockers</strong> can be used to treat the symptoms of thyrotoxicosis. In the <strong>hypothyroid phase</strong>, if the levels of thyroid hormones are too low, then <strong>levothyroxine</strong> might be required. However, <strong>antithyroid</strong> <strong>drugs</strong> are <strong>not given </strong>in the thyrotoxic phase.</p><hr><h3>Related Pearl: Causes of Hypothyroidism</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary </strong></p>\n<p>(Low T3, T4 &rarr; Raised TSH levels)</p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n<p><strong> </strong>(Low TSH levels &rarr; Low T3, T4)</p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n<p><strong> </strong>(Low TRH &rarr; Low TSH &rarr; Low T3,T4)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hashimoto&rsquo;s thyroiditis</strong></p>\n<p>RAI therapy for Grave&rsquo;s disease</p>\n<p>Post thyroidectomy</p>\n<p>Excessive iodine intake - Wolff Chiakoff effect</p>\n<p>Subacute thyroiditis</p>\n<p>Medications: Antithyroid drugs, lithium</p>\n<p>Iodine deficiency, dyshormonogenesis</p>\n</td>\n<td>\n<p><strong>Pituitary tumour</strong></p>\n<p>Pituitary resection or ablation</p>\n</td>\n<td>\n<p><strong>Hypothalamic insufficiency</strong></p>\n<p>Resistance to thyroid hormone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9447",
      "difficulty": "medium"
    },
    {
      "text": "A young patient is brought to the emergency room in a comatose state. He weighs around 70 kg. On examination, his serum glucose levels were found to be 500 mg/dL, arterial pH is 7.33, with increased plasma ketone levels. His serum potassium levels are normal. What is the bolus dose of insulin that should be administered immediately to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "7 units of short acting regular insulin intravenously"
        },
        {
          "id": 2,
          "text": "7 units of short acting insulin subcutaneously"
        },
        {
          "id": 3,
          "text": "14 units of short acting insulin intravenously"
        },
        {
          "id": 4,
          "text": "14 units of short acting regular insulin intravenously"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the above clinical scenario, the patient is likely to have <strong>diabetic ketoacidosis (DKA). </strong>The dose of insulin that should be immediately administered to this patient is<strong> 0.1 units per kg.</strong> Since the patient weighs around <strong>70 Kg </strong>he should be administered <strong>7 units</strong> <strong>intravenously.</strong></p>\n<p><strong>Diabetic ketoacidosis </strong>is an <strong>acute complication </strong>of <strong>type 1 diabetes mellitus.</strong> The symptoms include <strong>nausea, vomiting, thirst/polyuria, severe abdominal pain,</strong> and <strong>shortness of breath</strong>. It is <strong>precipitated </strong>by various events like <strong>inadequate insulin</strong> administration,<strong> infection</strong> (pneumonia/UTI/ gastroenteritis/sepsis), infarction (cerebral, coronary, mesenteric, peripheral), drugs (cocaine), and pregnancy.</p>\n<p>Clinical signs:</p>\n<ul>\n<li><strong>Kussmaul breathing </strong>(deep, rapid breathing)</li>\n<li><strong>Fruity odor</strong> on the patient’s breath (<strong>acetone breath</strong>)</li>\n<li><strong>Tachycardia</strong></li>\n<li><strong>Dehydration</strong></li>\n<li><strong>Hypotension</strong></li>\n</ul>\n<p>Blood parameters:</p>\n<ul>\n<li><strong>Hyperglycemia</strong> – 250–600 mg%</li>\n<li>Pseudohyponatremia - there is a 1.6-mmol/L reduction in serum sodium level for each 5.6-mmol/L rise in the serum glucose level.</li>\n<li class=\"p1\"><strong>Overall total body K<sup>+</sup> deficit, however, the serum K<sup>+</sup> at presentation may be mildly elevated, secondary to the acidosis.</strong></li>\n<li class=\"p1\">Osmolality – 300–320 mOsm/kg</li>\n<li><strong>Plasma ketones – positive</strong></li>\n<li><strong>Metabolic acidosis – increased anion gap </strong>(HAGMA)</li>\n<li><strong>Serum bicarbonate</strong> &lt;15 meq/L – best initial investigation</li>\n<li>Hypertriglyceridemia</li>\n<li>Hyperamylasemia</li>\n</ul>\n<p>The algorithm for the management of DKA is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/844477bd239d46468a918baef16203a7x1280x2846.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9445",
      "difficulty": "medium"
    },
    {
      "text": "An intern is asked to insert Ryle's tube in a young patient. He performs the following steps.<div class='question-desc-html'><p>He made the patient sit in the upright position and assessed for the nasal septal deviation. He instructed the patient to sniff and swallow 2% viscous lignocaine. Estimation of the length of insertion was done by measuring the distance from the tip of the nose, around the ear, and down to the xiphisternum. He inserted a 16 Fr NG tube in the more blocked nose so as to allow maximal breathing in the patient. At last, he confirmed the&nbsp;proper placement of the NG tube by aspirating the gastric contents.&nbsp;</p>\n<p>Comment about the above procedure:</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "The intern has used correct method for anesthetising the patient before procedure"
        },
        {
          "id": 2,
          "text": "Length of insertion is measured by the distance from the tip of the nose, jaw, and to xiphisternum."
        },
        {
          "id": 3,
          "text": "The size of the nasogastric tube is too small in the above scenario"
        },
        {
          "id": 4,
          "text": "Inserting the nasogastric tube in more blocked nose is correct"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The intern has&nbsp;instructed the patient to sniff and swallow 2% viscous lignocaine. This is the correct method of anaesthetising the patient before the procedure.</p>\n<p>Indications of nasogastric (NG) tube insertion</p>\n<p>Diagnostic indications for NG intubation include the following:</p>\n<ul>\n<li>\n<div class=\"topbullet\">Evaluation of upper gastrointestinal (GI) bleeding (ie, presence, volume)</div>\n</li>\n<li>\n<div class=\"topbullet\">Aspiration of gastric fluid content</div>\n</li>\n<li>\n<div class=\"topbullet\">Identification of the esophagus and stomach on a chest radiograph</div>\n</li>\n<li>\n<div class=\"topbullet\">Administration of radiographic contrast to the GI tract&nbsp;</div>\n</li>\n</ul>\n<p>Therapeutic indications for NG intubation include the following:</p>\n<ul>\n<li>\n<div class=\"topbullet\">Gastric decompression</div>\n</li>\n<li>\n<div class=\"topbullet\">Relief of symptoms and bowel rest in the setting of small-bowel obstruction</div>\n</li>\n<li>\n<div class=\"topbullet\">Aspiration of gastric content from recent ingestion of toxic material</div>\n</li>\n<li>\n<div class=\"topbullet\">Administration of medication</div>\n</li>\n<li>\n<div class=\"topbullet\">Feeding</div>\n</li>\n<li>\n<div class=\"topbullet\">Bowel irrigation</div>\n</li>\n<li>\n<div class=\"topbullet\">NG tube can be kept following corrosive ingestion for the development of a&nbsp;tract in the esophagus that subsequently can be used for balloon dilatation</div>\n</li>\n</ul>\n<p>The procedure of nasogastric tube insertion</p>\n<ul>\n<li>Explain the procedure of the nasogastric tube insertion to the patient and the patient attenders.</li>\n<li>Examine the patient's nostril for any blockade and septal deviation. Ask him to close each nostril and breathe. The tube has to be inserted in the <strong>more patent nostril.</strong></li>\n<li>Tilt the head of the patient backwards and ask him to slowly <strong>sniff and swallow 2% lidocaine.</strong> Wait for 5-10 minutes for the anesthesia to act.</li>\n<li>Estimate the length of insertion by measuring the distance from the tip of the nose, around the ear, and up to the xiphisternum.&nbsp;</li>\n<li>Position the patient <strong>sitting upright with the neck partially flexed.</strong> Ask the patient to hold the cup of water in his or her hand and put the straw in his or her mouth. Lubricate the distal tip of the NG tube.</li>\n<li>Now gently insert the tube into the nose. <strong>16-18 Fr</strong> tube is commonly used in adults. When the tube reaches the nasopharynx, there is a resistance felt. Ask the patient to swallow water through a straw.&nbsp;</li>\n<li>Continue to advance the NG tube until the distance of the estimated length is reached.</li>\n</ul>\n<p>&nbsp;Confirmation of the correct position is done by the following:</p>\n<ul>\n<li>Auscultation in the epigastric area while injecting a bolus of air</li>\n<li>Aspiration of gastric contents</li>\n<li>Chest radiograph</li>\n<li>Colorimetric capnography</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aba13fe6676d4d7b84713d3f1d288264x720x540.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9428",
      "difficulty": "hard"
    },
    {
      "text": "A surgical resident got his skin cut with a knife while he was operating on a patient diagnosed with hepatitis B infection. His anti-HBs levels were 45 mlU/ml. What will you do next?",
      "choices": [
        {
          "id": 1,
          "text": "Give hepatitis B hyperimmune globulin and start hepatitis B vaccination"
        },
        {
          "id": 2,
          "text": "No need of prophylaxis"
        },
        {
          "id": 3,
          "text": "Start hepatitis B vaccination"
        },
        {
          "id": 4,
          "text": "Give hepatitis B hyperimmune globulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In this scenario, since the anti-HBs antibodies titer in the resident is <strong>more than&nbsp;10 mIU/ml</strong>, he would <strong>not need any further prophylaxis.</strong></p>\n<p>Post-exposure prophylaxis of Hepatitis B:</p>\n<p>Scenario 1- The <strong>source</strong> is HBsAg <strong>negative</strong></p>\n<ul>\n<li>If the healthcare worker is not vaccinated- Initiate vaccination in the healthcare worker</li>\n<li>If the healthcare worker is already vaccinated- No need for any action</li>\n</ul>\n<p>Scenario 2-&nbsp;The <strong>source</strong> is HBsAg <strong>positive</strong></p>\n<ul>\n<li>If the healthcare worker is not vaccinated- Administer hepatitis B hyperimmune globulin (HBIG) single-dose and initiate vaccination.&nbsp;</li>\n<li>If the healthcare worker is vaccinated- Measure the anti-HBs antibody titers in him. If the levels are&nbsp;<strong>more than&nbsp;10 mIU/ml</strong>,&nbsp;<strong>no further prophylaxis is required.</strong>\n<ul>\n<li>If the levels are less than 10mIU/mL, then administer HBIG single dose and reinitiate vaccination.</li>\n<li>If the levels are less than 10mIU/mL, even after two complete series of vaccination- Give two doses of HBIG one month apart.</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: 2021 NACO Guidelines on Post-exposure Prophylaxis (PEP) for HIV</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Exposure Code</strong></p>\n</td>\n<td>\n<p><strong>HIV Source Code</strong></p>\n</td>\n<td>\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PEP Recommendation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Not required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>&nbsp;1/2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2/3</p>\n</td>\n<td>\n<p>Not known</p>\n</td>\n<td>\n<p>Consider PEP if HIV prevalence is high in the given population</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>Exposure Codes</strong></p>\n<ul>\n<li>EC1: <strong>Mild exposure:</strong> mucous membrane/non-intact skin with small volumes/eyes or mucous membrane or subcutaneous injections following small-bore needles</li>\n<li>EC2:&nbsp;<strong>Moderate exposure: </strong>mucous membrane/non-intact skin with large volumes or percutaneous superficial exposure with a solid needle</li>\n<li>EC3:&nbsp;<strong>Severe exposure: </strong>percutaneous with large volume by hollow needle, deep puncture</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>HIV Source Codes</strong></p>\n<ul>\n<li>SC 1- HIV +ve, asymptomatic, CD count high, low viral load</li>\n<li>SC 2- HIV +ve, symptomatic, CD count low, high viral load</li>\n<li>SC unknown: HIV status unknown</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>Recommended PEP regimens</strong></p>\n<p>1) <strong>Adolescents and Adults</strong> (&gt;10 years of age and &gt;30 kg weight): Tenofovir 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg</p>\n<p>2) <strong>Children&nbsp;</strong>(&gt;6 years of age and &gt;20 kg weight): Zidovudine&nbsp;(dosage as per weight band) + Lamivudine (dosage as per weight band) + Dolutegravir 50 mg</p>\n<ul>\n<li aria-level=\"1\">PEP must be initiated ideally <strong>within 2 hours</strong> and certainly within 72 hours.</li>\n<li aria-level=\"1\">Duration of PEP: <strong>28 days/4weeks</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9419",
      "difficulty": "medium"
    },
    {
      "text": "An HIV-positive patient has the following serology results. What is the management of this patient?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Markers</strong></p>\n</td>\n<td><strong>Result</strong></td>\n</tr>\n<tr>\n<td>HBsAg</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>anti-HBc</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>IgM anti-HBc</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>anti-HBs</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Tenofovir + emtricitabine + abacavir"
        },
        {
          "id": 2,
          "text": "Tenofovir + lamivudine + dolutegravir"
        },
        {
          "id": 3,
          "text": "Lamivudine + emtricitabine + nevirapine"
        },
        {
          "id": 4,
          "text": "Tenofovir + lamivudine + efavirenz"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The given clinical scenario is suggestive of&nbsp;an <strong>acute infection</strong> with <strong>hepatitis B</strong> virus. The preferred regimen in the management of HIV-1 and hepatitis B <strong>co-infection</strong> is <strong>tenofovir + lamivudine + dolutegravir.&nbsp;</strong></p>\n<p class=\"p1\">This regimen is also the first-line management in adults, adolescents, pregnant women, and&nbsp;HIV-TB co-infection.&nbsp;</p>\n<p>Antivirals that are effective against <strong>hepatitis C</strong> infection are&nbsp;<strong>sofosbuvir, grazoprevir</strong>&nbsp;and<strong> glecaprevir</strong>.</p>\n<p>*Note: Pearl attached below has been updated according to the NACO ART guidelines 2021. Efavirenz has been replaced by <strong>Dolutegravir</strong> as per the new guidelines.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: NACO ART Guidelines- 2021</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">ART regimen</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">First-line for:</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Tenofovir + Lamivudine + Dolutegravir</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li>All PLHIV who are<strong> age &gt;10 years and body weight &gt;30 kg&nbsp;</strong>with <strong>HIV-1, HIV-2, HIV 1&amp;2 co-infection</strong>&nbsp;who have not received any ART&nbsp;</li>\n<li aria-level=\"1\">Those with <strong>HIV-TB and HIV hepatitis co-infections</strong></li>\n<li aria-level=\"1\"><strong>Pregnant women</strong>, pregnant women presenting in <strong>active labour</strong> and <strong>breastfeeding women</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Abacavir + Lamivudine + Efavirenz</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li aria-level=\"1\">All PLHIV with <strong>abnormal serum creatinine</strong> values&nbsp;</li>\n<li aria-level=\"1\">All PLHIV with <strong>bodyweight less &lt;30 kg</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Tenofovir + Lamivudine + Efavirenz /Lopinavir /Ritonavir</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li>Women of childbearing age group who do not wish to take Dolutegravir</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li class=\"p1\">All PLHIV who were on the previous recommended regime&nbsp;(Tenofovir+Lamivudine+Efavirenz) to be counselled to switch to new regime. Continue older regime if response is good</li>\n<li class=\"p1\">Women in child-bearing age group to be counselled about Dolutegravir with opt-out option before switching to new regime</li>\n</ul>\n<p>*PLHIV: People living with HIV</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9416",
      "difficulty": "medium"
    },
    {
      "text": "A young woman visits the doctor because she has stiffness in her wrist and small joints of the hand. It is more in the early morning and improves with physical activity. On examination, swelling and pain are noted in the wrists, metacarpophalangeal joints, and proximal interphalangeal joints. Laboratory investigations reveal high titers of anti-CCP antibodies. Which of the following is the most common pulmonary manifestation of this disease?",
      "choices": [
        {
          "id": 1,
          "text": "Pleuritis"
        },
        {
          "id": 2,
          "text": "Usual interstitial pneumonia"
        },
        {
          "id": 3,
          "text": "Non-infectious pneumonia"
        },
        {
          "id": 4,
          "text": "Non-specific interstitial pneumonia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features are suggestive of rheumatoid arthritis. The <strong>most common</strong> <strong>pulmonary</strong> manifestation of this disease is <strong>Pleuritis</strong>.&nbsp;<strong>Clinical features of rheumatoid arthritis:</strong></p>\n<p><strong>Joints:</strong>&nbsp;Patients have early morning stiffness of joints of the hand. This stiffness persists for <strong>around 1 hour</strong> and <strong>improves</strong> with <strong>physical activity</strong>. The most commonly involved joints are&nbsp;<strong>wrists, metacarpophalangeal (MCP), and proximal interphalangeal (PIP) joints</strong>. Chronic progressive destruction of the joint leads to deformities.</p>\n<ul>\n<li><strong>Ulnar deviation:</strong>&nbsp;Results from subluxation of the MCP joints, with subluxation, or partial dislocation, of the proximal phalanx to the volar side of the hand.</li>\n<li class=\"p1\"><strong>Swan-neck deformity:</strong>&nbsp;Hyperextension of the PIP joint with flexion of the distal interphalangeal (DIP) joint.&nbsp;</li>\n<li class=\"p1\"><strong>Boutonni&egrave;re deformity:</strong>&nbsp;Flexion of the PIP joint with hyperextension of the DIP joint</li>\n<li class=\"p1\"><strong>Z-line deformity:</strong>&nbsp;Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint</li>\n</ul>\n<p>Extra-articular features:</p>\n<p><strong>Skin:</strong>&nbsp;Firm and non-tender nodules that are adherent to the periosteum, tendons, or bursae</p>\n<p><strong>Pulmonary</strong>: <strong>Pleuritis</strong> is the most common pulmonary manifestation seen in Rheumatoid arthritis.&nbsp;<strong>Usual interstitial pneumonia</strong> (UIP), a type of ILD is seen more commonly in males and smokers.</p>\n<p><strong>Cardiac</strong>: It can cause pericarditis, cardiomyopathy, mitral regurgitation, etc.</p>\n<p><strong>Rheumatoid</strong>:vasculitis presents as&nbsp;petechiae, purpura, digital infarcts, gangrene, livedo reticularis</p>\n<p><strong>Hematological</strong>: Normochromic normocytic anemia</p>\n<p>Rheumatoid arthritis disease is commonly associated with coronary artery disease, carotid atherosclerosis, osteoporosis, and hypoandrogenism.&nbsp;</p><hr><h3>Related Pearl: Deformities in rheumatoid arthritis</h3><p><strong>Boutonni&egrave;re deformity: </strong>Flexion of the PIP joint with hyperextension of the DIP joint.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0250f1148284de1bd77c8d6e470c56fx720x960.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Swan-neck deformity</strong>: Hyperextension of the PIP joint with flexion of the DIP joint.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/560c6a73ecfc46e7aed6682bc24af2a4x720x1017.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Z line deformity: </strong>Radial deviation of the wrist with ulnar deviation of digits.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c60e1966a5314bbf8fd6c20a5ed7f625x800x600.JPEG\" alt=\"Pearl Image\"><p>Eversion at hindfoot (subtalar joint), hallux valgus (shown below), hammertoe.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/798b7febef7a44699a664b1f1a5363cdx720x919.JPEG\" alt=\"Pearl Image\"><p>Windswept deformities of toes - Valgus deformities of toes in one foot and varus in the other foot.&nbsp;</p>\n<p><strong>Piano-key movement </strong>of the ulnar styloid.&nbsp;</p>\n<p><strong>Trigger finger</strong> due to flexor tendon synovitis.&nbsp;</p><hr><h3>Related Pearl: Joint Involvement in Various Arthritis</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Joint Disorders</strong></td>\n<td><strong>Joints Commonly Involved</strong></td>\n<td>\n<p><strong>Joints Com</strong><strong>monly </strong><strong>Spared</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Osteoarthritis</strong></p>\n</td>\n<td>\n<p>Cervical and lumbosacral spine, PIP, DIP,&nbsp;1st CMC, hip, knee,&nbsp;1st MTP,&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;Elbow, Wrist, Ankle, MCP&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Rheumatoid Arthritis</strong></td>\n<td>Shoulder, Wrist, MCP, PIP, Knee, MTP&nbsp;</td>\n<td>DIP&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Ankylosing Spondylitis</strong></td>\n<td>Sacroiliac joint, intervertebral joints</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Psoriatic Arthritis</strong></td>\n<td>PIP,&nbsp;DIP</td>\n<td>Ray distribution*&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Ray distribution: Joint involvement tends to follow a pattern with all of the joints of one finger involved sparing the adjacent finger completely.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9398",
      "difficulty": "medium"
    },
    {
      "text": "A 69-year-old woman presents to her primary care physician complaining of fatigue and achiness in her shoulders and hips. Her whole body feels stiff in the morning for at least 60- 90 minutes. She also complains of severe headaches and pain in the scalp and jaw. On physical examination, she has decreased the active range of motion of her shoulders and hips. She has no muscle tenderness. Strength is 5/5 in all four extremities. Neurologic examination is insignificant.<div class='question-desc-html'><p>Laboratory tests show:<br />WBC count: 8600/mm&sup3;<br />Hemoglobin: 10.4 g/dL<br />Platelet count: 3,00,000/mm&sup3;<br />Erythrocyte sedimentation rate: 120 mm/hr<br />Creatine kinase levels- Normal<br />A short course of prednisone leads to an almost complete resolution of symptoms. Which of the following is the most likely diagnosis?</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 2,
          "text": "Fibromyalgia"
        },
        {
          "id": 3,
          "text": "Polymyositis"
        },
        {
          "id": 4,
          "text": "Polymyalgia rheumatica"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient in this scenario is an elderly woman and complains of stiffness in her shoulders and hips. This symptom is associated with headache, anemia, elevated ESR, and a very good response to prednisone. These suggest that the patient has <strong>polymyalgia rheumatica.</strong></p>\n<p>Polymyalgia rheumatica is&nbsp;characterized by&nbsp;<strong>stiffness&nbsp;</strong>and<strong>&nbsp;pain</strong>&nbsp;in the muscles of the&nbsp;<strong>neck</strong>,&nbsp;<strong>shoulder</strong>, back, hips, and thigh. The stiffness is usually in the <strong>early morning</strong> and lasts for at least 1 hour. It can occur in isolation or can also occur along with giant cell arteritis.</p>\n<p>Giant cell arteritis is the inflammation of the medium to large-sized arteries. It commonly involves the temporal artery. The disease is commonly seen in&nbsp;<strong>females</strong>&nbsp;over&nbsp;<strong>50</strong>&nbsp;years of age. It is characterized by fever, anemia, and headache. Depending on the artery involved, the patient may have tenderness over the affected artery, scalp pain,&nbsp;<strong>jaw</strong>&nbsp;and tongue claudication.</p>\n<p>Laboratory investigations reveal&nbsp;<strong>elevated ESR</strong>&nbsp;and normochromic normocytic anemia. It is confirmed by temporal artery biopsy.</p>\n<p>The patients have a good response to&nbsp;<strong>glucocorticoid</strong>&nbsp;therapy. Glucocorticoids should be started as soon as the disease is suspected in order to prevent visual loss. Untreated patients may develop&nbsp;<strong>ischemic optic neuropathy</strong>.</p>\n<p>Other options</p>\n<p>Option A- Rheumatoid arthritis&nbsp;is usually seen in females between <strong>25-55 years</strong> of age. The most common joints involved are&nbsp;the <strong>wrists,</strong> metacarpophalangeal<strong> (MCP),</strong> and proximal interphalangeal <strong>(PIP)</strong> joints.&nbsp;</p>\n<p>Option B- Patients with fibromyalgia&nbsp;complain of <strong>diffuse musculoskeletal pain</strong>. The pain is <strong>poorly localized</strong>. Physical examination typically reveals <strong>muscle tenderness</strong>. Routine <strong>laboratory</strong> tests appear <strong>normal.</strong></p>\n<p class=\"p1\">Option C- Polymyositis presents with&nbsp;symmetric and proximal <strong>muscle weakness</strong> that worsens over several weeks to months. There may be&nbsp;associated heart, lung, and joint involvement as well. <strong>Creatine kinase</strong> levels are always <strong>elevated</strong></p><hr><h3>Related Pearl: Important Vasculitis with Features</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vasculitis</strong></p>\n</td>\n<td>\n<p><strong>Predominant vessel involved</strong></p>\n</td>\n<td>\n<p><strong>Inflammatory cells</strong></p>\n</td>\n<td>\n<p><strong>Other features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Temporal arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>Temporal, vertebral and ophthalmic arteries, aorta</p>\n</td>\n<td>\n<p>Lymphocytes, and macrophages</p>\n</td>\n<td>\n<p>&gt;40 years old, polymyalgia rheumatica, granulomas, giant cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Takayasu Arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>(Medium-sized and large arteries) Aortic arch, great vessels, pulmonary artery, coronary and renal arteries</p>\n</td>\n<td>\n<p>Lymphocytes, macrophages, neutrophils, granulomas, giant cells</p>\n</td>\n<td>\n<p>Pulseless disease</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Polyarteritis Nodosa</strong></p>\n</td>\n<td>\n<p>Small or medium-sized muscular arteries, typically involving renal and visceral vessels</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Spares pulmonary vessels, 30% of patients with&nbsp; chronic hepatitis B</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microscopic polyangiitis</strong></p>\n</td>\n<td>\n<p>Capillaries, small arterioles, venules</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Necrotizing glomerulonephritism (90% of patients) and pulmonary capillaritis leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Churg-Strauss&nbsp;</strong><strong>Syndrome</strong></p>\n</td>\n<td>\n<p>Medium and small arteries</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Eosinophils (required), lymphocytes, macrophages, neutrophils</p>\n</td>\n<td>\n<p>Associated with asthma, allergic rhinitis, lung infiltrates, peripheral hypereosinophilia, and extravascular necrotizing granulomata.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9394",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman presents with severe joint pains for 1 month. She also says her skin feels firm and tight for the past 6 months and progressed rapidly since then. Further history taking reveals features of mild Raynaud's syndrome since 6 months. On examination, the skin over the fingers, legs, arms, and trunk appear firm and indurated on palpation. Which of the following antibodies will most likely be elevated in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-double-stranded DNA antibody"
        },
        {
          "id": 2,
          "text": "Anti–topoisomerase I antibody"
        },
        {
          "id": 3,
          "text": "Anti-Smith antibody"
        },
        {
          "id": 4,
          "text": "Anticentromere antibody"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of&nbsp;<strong>severe arthralgia </strong>and&nbsp;<strong>diffuse involvement</strong> of the <strong>skin </strong>with<strong> rapid progression</strong>, along with a recent history of&nbsp;<strong>Raynaud's phenomenon,</strong>&nbsp;is suggestive of <strong>diffuse systemic sclerosis.</strong>&nbsp;<strong>Anti&ndash;topoisomerase I antibody</strong> is most likely to be elevated in this patient.</p>\n<p>Reasons why this cannot be limited systemic sclerosis:</p>\n<ul>\n<li>The onset of Raynaud's syndrome coincides with the onset of skin symptoms, whereas in <strong>limited systemic sclerosis,</strong>&nbsp;it precedes skin symptoms and has a <strong>history of over a decade</strong>.</li>\n<li>Here Raynaud's is <strong>less severe</strong>, whereas in <strong>limited systemic sclerosis</strong>&nbsp;it is <strong>more severe.</strong></li>\n<li>Here, the skin involvement is diffuse, including the<strong> trunk</strong>, and showed<strong> rapid progression,</strong>&nbsp;which are features of diffuse systemic sclerosis.</li>\n</ul>\n<p>Systemic sclerosis is a chronic and progressive disease that involves <strong>sclerosis of the skin</strong> and the organs. It can be divided into&nbsp;limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSC) depending on the extent of skin involvement.</p>\n<p>In<strong> lcSSc</strong>, the skin involvement has a slow progression and is limited to fingers, <strong>distal to elbows</strong>, face. This disease has a slow progression. On the contrary, in<strong> dcSSc</strong>, the skin involvement is early and rapid. It can involve fingers, extremities, face, and <strong>trunk.</strong> They also have<strong> severe joint pains</strong> and musculoskeletal involvement.</p>\n<p>Other options:</p>\n<p>Options A and C- <strong>Anti-double-stranded DNA antibody</strong>&nbsp;and <strong>anti-Smith antibody</strong> are seen <strong>systemic lupus erythematosus.</strong> The patients might have a rash over the malar eminences or circular lesions with slightly raised, scaly hyperpigmented erythematous rims. They might also have swelling and tenderness in their hands, wrists, and knees.</p>\n<p>Option D- <strong>Anti-centromere antibody</strong> is seen in <strong>limited cutaneous systemic sclerosis</strong>. Here, the skin involvement is seen distal to the elbow, in the extremities, and <strong>distal to the elbows.</strong></p><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9389",
      "difficulty": "hard"
    },
    {
      "text": "A 23-year-old man presented with diarrhea, floating stools, and weight loss for 3 months. The biopsy of the intestine is shown below. His symptoms improved with folic acid intake. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Celiac disease"
        },
        {
          "id": 2,
          "text": "Whipple’s disease"
        },
        {
          "id": 3,
          "text": "Tropical sprue"
        },
        {
          "id": 4,
          "text": "Short bowel syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario of a young man presenting with diarrhea, floating stools, and weight loss with histopathology showing <strong>partial villous atrophy</strong> and marked intraepithelial lymphocytosis indicating inflammation of lamina propria and improvement with folic acid intake is suggestive of <strong>tropical sprue</strong>.</p>\n<p><strong>Tropical sprue</strong> is an acquired <strong>malabsorptive</strong> condition that causes chronic diarrhea, steatorrhea, weight loss, and folate and vitamin B12 malabsorption. It occurs in some tropical regions and is often considered a postinfectious complication. Diagnosis is based on a <strong>small intestinal biopsy</strong> showing villous atrophy and chronic inflammation, similar to celiac disease. However, tropical sprue is <strong>unresponsive</strong> to a <strong>gluten-free diet</strong>.</p>\n<p>Treatment includes broad-spectrum antibiotics (e.g., <strong>tetracycline</strong> for up to six months) and <strong>folic acid supplementation</strong>, which can lead to improvement within weeks. Patients often recover fully if they leave the endemic area. Folic acid alone can improve symptoms and correct hematologic deficiencies, but antibiotics are typically needed for complete resolution.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Celiac disease</strong> is a gluten-sensitive enteropathy. Patients present with iron deficiency anemia, weight loss, diarrhea, and malabsorption. A biopsy reveals <strong>blunting of the villi</strong>, crypt hyperplasia, and inflammation propria. <strong>Tissue transglutaminase </strong>is involved in the pathogenesis of this disorder. Patients <strong>respond </strong>to a <strong>gluten</strong>-free diet. The image below shows histopathological findings seen in celiac disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f21ca58ddcea4cde873759dd93ff248bx761x674.JPEG\" alt=\"Explanation Image\"><p>Option B: <strong>Whipple's disease</strong> is a multiorgan disease caused by the bacteria <em><strong>Tropheryma whipplei.</strong></em> It is characterized by arthralgia, arthritis, weight loss, diarrhea, abdominal pain, and psychiatric manifestations. The organism can be detected by tissue immunohistochemistry and tissue staining for <strong>PAS-positive macrophages</strong>. The below image shows the PAS stain in Whipple's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01e1db2c217148d5a7278e99fbe85309x900x675.JPEG\" alt=\"Explanation Image\"><p>Option D: <strong>Short bowel syndrome</strong> is characterized by extensive removal of the small intestine. The loss of small-bowel surface area leads to severe diarrhea, weight loss, and problems absorbing fat, protein, and carbohydrates.</p><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/12b10219a48f423197e732661e055dd0.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9370",
      "difficulty": "medium"
    },
    {
      "text": "Mr Ramesh, who is posted for elective surgery has the following Hepatitis B serology.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Markers</strong></p>\n</td>\n<td><strong>Result</strong></td>\n</tr>\n<tr>\n<td>HBsAg</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>anti-HBc</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>anti-HBs</td>\n<td>Positive</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>What is your interpretation?</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "The patient has natural immunity against Hepatitis B"
        },
        {
          "id": 2,
          "text": "The patient is vaccinated against hepatitis B infection"
        },
        {
          "id": 3,
          "text": "The patient had an infection which resolved"
        },
        {
          "id": 4,
          "text": "The patient has chronic Hepatitis B infection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above serology suggests that the patient is <strong>vaccinated against Hepatitis B infection.</strong></p>\n<p>Hepatitis B surface antigen (<strong>HBsAg</strong>): The presence of this antigen means that the person is <strong>infectious.</strong></p>\n<p>Hepatitis B surface antibody (<strong>anti-HBs</strong>): indicates <strong>recovery</strong> and <strong>immunity</strong> against hepatitis B</p>\n<p>Total hepatitis B core antibody (<strong>anti-HB</strong>c): It means that the person has/had an <strong>infection</strong> with <strong>hepatitis B.&nbsp;</strong>If the antibody is IgM type it means a recent infection with hepatitis B virus (&lt;6 months). It indicates a recent infection.&nbsp;If the antibody is IgG type it means a past or chronic infection with hepatitis B virus.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Marker</strong></td>\n<td><strong>Result</strong></td>\n<td><strong>Scenario</strong></td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc&nbsp;</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Negative&nbsp;</p>\n<p>Negative</p>\n<p>Negative</p>\n</td>\n<td>Susceptible</td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc&nbsp;</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Negative</p>\n<p>Positive</p>\n<p>Positive</p>\n</td>\n<td>Immune due to natural infection</td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc&nbsp;</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Negative</p>\n<p>negative</p>\n<p>Positive</p>\n</td>\n<td>Immune due to hepatitis B vaccination</td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc</p>\n<p>IgM anti-HBc</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Positive</p>\n<p>Positive</p>\n<p>Positive</p>\n<p>Negative</p>\n</td>\n<td>Acutely infected</td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc</p>\n<p>IgM anti-HBc</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Positive</p>\n<p>Positive</p>\n<p>Negative</p>\n<p>Negative</p>\n</td>\n<td>Chronically infected</td>\n</tr>\n<tr>\n<td>\n<p>HBsAg</p>\n<p>anti-HBc&nbsp;</p>\n<p>anti-HBs</p>\n</td>\n<td>\n<p>Negative</p>\n<p>Positive</p>\n<p>Negative</p>\n</td>\n<td>\n<p>Interpretation unclear; four possibilities:</p>\n<p>Resolved infection (most common)&nbsp;F</p>\n<p>false-positive anti-HBc, thus susceptible&nbsp;</p>\n<p>Low-level chronic infection</p>\n<p>Resolving acute infection</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: The most commons in hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>CAUSE</strong></td>\n<td><strong>ETIOLOGICAL AGENT</strong></td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in children</td>\n<td>HepA</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in adults</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis in pregnancy</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis related mortality in pregnancy</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure (Western countries)</td>\n<td>Paracetamol poisoning</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure in India</td>\n<td> Viral hepatitis (B and E)</td>\n</tr>\n<tr>\n<td>Most common cause of viral fulminant hepatitis</td>\n<td> HepE</td>\n</tr>\n<tr>\n<td>Highest risk of progresion from acute viral hepatitis to fulminant hepatitis</td>\n<td>HepD </td>\n</tr>\n<tr>\n<td>Most common cause of chronic hepatitis (prevalence)</td>\n<td>HepB (450 million)</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis, leading to chronic<br />hepatitis (prevalence)</td>\n<td> HepC (150 million)</td>\n</tr>\n<tr>\n<td>Maximum risk and max potential of chronicity</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of carrier State</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of cirrhosis</td>\n<td>Alcohol</td>\n</tr>\n<tr>\n<td>Most common viral cause of cirrhosis</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatocellular carcinoma</td>\n<td>HepB</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Extrahepatic Manifestations of Hepatitis B and C</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hepatitis B</strong></td>\n<td><strong>Hepatitis C</strong></td>\n</tr>\n<tr>\n<td>Hematological</td>\n<td>\n<p>Aplastic anemia</p>\n</td>\n<td>\n<p>Essential mixed cryoglobulinemia</p>\n</td>\n</tr>\n<tr>\n<td>Renal</td>\n<td>\n<p>Membranous glomerulonephritis (hepatitis B &gt; C)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Membranous glomerulonephritis &nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Vascular</td>\n<td>\n<p>Polyarteritis nodosa (hepatitis B&gt;C)</p>\n</td>\n<td>\n<p>Leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>Dermatologic</td>\n<td>\n<p>Erythema multiforme (Hepatitis B&gt;C)</p>\n<p>Urticaria</p>\n<p>Serum sickness</p>\n<p>Infantile papular acrodermatitis (Gianotti&ndash;Crosti syndrome)</p>\n<p>Erythema nodosum</p>\n</td>\n<td>\n<p>Erythema multiforme</p>\n<p>Sporadic porphyria cutanea tarda</p>\n<p>Lichen planus</p>\n<p>Necrolytic acral erythema</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Hepatitis C also increases the risk of:</p>\n<ul>\n<li>Non-Hodgkin&rsquo;s lymphoma</li>\n<li>Idiopathic thrombocytopenic purpura</li>\n<li>Autoimmune hemolytic anemia</li>\n<li>Diabetes mellitus</li>\n<li>Autoimmune thyroiditis &nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9365",
      "difficulty": "easy"
    },
    {
      "text": "A 70-year-old woman was brought with complaints of progressive memory loss that began three years back. She recently forgot her way back home while returning from a market. There is no history of personality changes, rigidity, or gait disturbances. Which of the following is not a risk factor for the development of this disease?",
      "choices": [
        {
          "id": 1,
          "text": "Use of non steroidal anti-inflammatory drugs"
        },
        {
          "id": 2,
          "text": "Down's syndrome"
        },
        {
          "id": 3,
          "text": "E4 allele of Apo E gene"
        },
        {
          "id": 4,
          "text": "Female sex"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of <strong>progressive memory</strong>&nbsp;<strong>loss</strong> in an <strong>elderly woman,</strong>&nbsp;without any associated symptoms, is suggestive of <strong>Alzheimer&rsquo;s disease </strong>(AD).<strong>&nbsp;</strong>The use of non-steroidal&nbsp;anti-inflammatory drugs (NSAID) is not a risk factor for this disease.</p>\n<p>Alzheimer's disease is a condition characterized by <strong>progressive</strong> deterioration of memory. It is the <strong>most common cause</strong> of dementia in the elderly.</p>\n<p>The risk factors include:</p>\n<ul>\n<li>Age &gt;70 years and <strong>female</strong> gender</li>\n<li>Positive family history and&nbsp;<strong>Apo <span class=\"s1\">&epsilon;</span>4 allele</strong></li>\n<li class=\"p1\">Diabetes, hypertension, elevated levels of homocysteine and cholesterol&nbsp;</li>\n<li class=\"p1\">Diminished intake of folic acid, fruits, vegetables, red wine, and&nbsp;low levels of exercise</li>\n<li class=\"p1\"><strong>Down's syndrome.</strong></li>\n</ul>\n<p>Use of <strong>NSAIDs&nbsp;</strong>has been shown to be protective against AD.</p>\n<p>Pathology shows the presence of<strong> neuritic plaques and neurofibrillary tangles. </strong>A&nbsp;central core of amyloid, proteoglycans, ApoE,&nbsp;<span class=\"s1\">&alpha;</span>-antichymotrypsin, and other proteins form the neuritic plaques while neurofibrillary tangles are composed of silver-staining neuronal cytoplasmic fibrils made of abnormally phosphorylated tau proteins.&nbsp;</p>\n<p>Patients may have the following features</p>\n<ul>\n<li><strong>Memory impairment </strong>gets unrecognized in the early stages. Eventually, interference with daily activities like difficulty in keeping track of finances, driving, shopping, and housekeeping may be seen. In severe impairment, the patient easily gets lost and confused.</li>\n<li><strong>Language deficits</strong> appear as impairment in naming followed by comprehension and fluency.</li>\n<li>Patients have difficulty dressing, eating, copying geometric figures, and reading the clock due to their <strong>visuospatial deficits</strong>.</li>\n</ul>\n<p>It is treated with cholinesterase inhibitors like <strong>donepezil, galantamine, rivastigmine</strong>, and NMDA receptor antagonist like <strong>memantine.</strong></p><hr><h3>Related Pearl: Alzheimer’s disease</h3><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out </li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4 <strong><strong>(ApoE ε4 allele)</strong></strong>, Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion of the cholinergic neurons in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects. </p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia </li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\" alt=\"Pearl Image\"><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>. </li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibodies against the N-terminus of the Aβ peptide - <strong>l</strong><strong>ecanemab, donanemab</strong></li>\n</ul><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9360",
      "difficulty": "medium"
    },
    {
      "text": "An IT professional was found to have vitamin D deficiency during a routine health check-up. He purchased vitamin D 60,000 IU sachets over-the-counter and started consuming them every day. After two weeks, he presented with severe colicky pain over the renal angle. His vitamin D levels are found to be elevated (170 ng/mL). Which of the following medications will be helpful in treating this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Calcitonin"
        },
        {
          "id": 2,
          "text": "Aspirin"
        },
        {
          "id": 3,
          "text": "Trientine"
        },
        {
          "id": 4,
          "text": "Zinc"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario depicts <strong>vitamin D toxicity</strong>, which has led to hypercalcemia and <strong>renal stones</strong>. Among the given options, <strong>calcitonin</strong> can be used for the treatment of this condition.</p>\n<p><strong>Vitamin D toxicity</strong> occurs due to excessive intake of vitamin D supplements, usually in amounts of &gt;40,000–100,000 IU/day. The symptoms are mainly due to <strong>hypercalcemia</strong>. Laboratory investigations will show elevated serum vitamin D levels (&gt;100 ng/mL) and calcium.</p>\n<p>In such patients, vitamin D supplements should be discontinued immediately, along with restricted exposure to the sun and avoiding calcium supplements. Since vitamin D is stored in the body for a long time, the symptoms may persist for some days even after stopping the intake.</p>\n<p><strong>Calcitonin </strong>and<strong> bisphosphonates</strong> are used in cases of <strong>severe toxicity</strong> causing hypercalcemia. Some patients might require <strong>glucocorticoids</strong>, which lower plasma calcium levels by <strong>reducing calcium absorption</strong> from the intestines and <strong>increasing</strong> its <strong>urinary excretion</strong>. </p>\n<p>Other options</p>\n<p>Option B- <strong>Aspirin</strong> is used in the management of <strong>niacin-induced</strong> flushing.</p>\n<p>Options C and D- <strong>Trientine</strong> and <strong>zinc</strong> are copper chelators. They are mainly used in the treatment of <strong>Wilson's disease.</strong></p><hr><h3>Related Pearl: Causes of Hypercalcemia</h3><ul>\n<li><strong>Parathyroid</strong>-Related\n<ul>\n<li>Primary hyperparathyroidism\n<ul>\n<li>Adenoma(s)</li>\n<li>Multiple endocrine neoplasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li>Lithium therapy</li>\n<li>Familial hypocalciuric hypercalcemia</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>-Related\n<ul>\n<li>Solid tumour with metastases (breast)</li>\n<li>Solid tumour with humoral mediation of hypercalcemia (lung, kidney)</li>\n<li>Hematologic malignancies (multiple myeloma, lymphoma, leukemia)</li>\n</ul>\n</li>\n<li><strong>Vitamin</strong> <strong>D</strong>&ndash;Related\n<ul>\n<li>Vitamin D intoxication</li>\n<li>&uarr; 1,25(OH)2D :\n<ul>\n<li>Sarcoidosis and other granulomatous diseases</li>\n<li>Impaired 1,25(OH)2D metabolism due to 24-hydroxylase deficiency</li>\n</ul>\n</li>\n<li>Associated with <strong>high bone turnover</strong>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n<li>Thiazides</li>\n<li>Vitamin A intoxication</li>\n<li>Fat necrosis</li>\n</ul>\n</li>\n<li>Associated with <strong>renal failure</strong>\n<ul>\n<li>Severe secondary hyperparathyroidism</li>\n<li>Aluminium intoxication</li>\n<li>Milk-alkali syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9358",
      "difficulty": "medium"
    },
    {
      "text": "A young man is brought to the ER with weakness in both legs since yesterday. The weakness has progressed to his arms now and he is having difficulty in breathing. He had an episode of diarrhea 2 weeks ago. Physical examination shows flaccid paralysis in all four limbs and arreflexia. CSF examination shows elevated protein levels but normal cell count. What is the further management for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Intravenous corticosteroids"
        },
        {
          "id": 2,
          "text": "Intravenous immunoglobulin"
        },
        {
          "id": 3,
          "text": "Intravenous ceftriaxone plus vancomycin"
        },
        {
          "id": 4,
          "text": "Cyclosporine and tacrolimus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of ascending, flaccid type of paralysis following an episode of diarrhea 2 weeks ago, and CSF examination showing increased protein with normal cell count, point to a diagnosis of Guillain-Barr&eacute; syndrome (GBS).&nbsp;</p>\n<p><strong>Guillian-Barr&eacute; syndrome (GBS)</strong>&nbsp;is an acute,&nbsp;<strong>autoimmune</strong>&nbsp;<strong>polyneuropathy</strong>. The possible <strong>antecedent events</strong> include <strong>respiratory</strong> or <strong>gastrointestinal</strong> <strong>infections</strong>. The implicated organisms include <strong><em>Campylobacter jejuni</em></strong>, CMV, EBV, and <strong><em>Mycoplasma pneumonia</em></strong>.</p>\n<p>The usual presentation is <strong>symmetrical</strong>,&nbsp;<strong>ascending</strong>&nbsp;<strong>paralysis</strong>&nbsp;evolving over hours to a few days. The legs are usually more affected than the arms. Lower cranial nerves are also frequently involved, causing&nbsp;<strong>bulbar weakness</strong>&nbsp;and difficulty in maintaining an airway and handling secretions. Almost one-third of the patients require&nbsp;<strong>mechanical ventilation</strong>&nbsp;due to&nbsp;<strong>weakness of the respiratory muscles</strong>.&nbsp;<strong>Deep tendon reflexes</strong>&nbsp;also attenuate or&nbsp;<strong>disappear</strong>&nbsp;within a few days of onset.&nbsp;</p>\n<p>Sensations carried by large myelinated fibers like deep tendon reflexes and&nbsp;<strong>proprioception</strong>&nbsp;are also&nbsp;<strong>affected</strong>. Pain and temperature sensations are relatively preserved.&nbsp;<strong>Autonomic involvement</strong>&nbsp;usually presents with loss of vasomotor control with <strong>wide fluctuations in blood pressure</strong>&nbsp;and&nbsp;<strong>postural hypotension</strong>. <strong>Fever</strong> <strong>and constitutional symptoms</strong>&nbsp;are&nbsp;<strong>absent</strong>&nbsp;<strong>at</strong>&nbsp;the&nbsp;<strong>onset</strong>&nbsp;<strong>of</strong>&nbsp;the&nbsp;<strong>weakness</strong>. Similarly, bladder dysfunction occurs only in severe GBS and is transient. Prominent&nbsp;<strong>bladder dysfunction</strong>&nbsp;occurring&nbsp;<strong>early</strong>&nbsp;in the disease course&nbsp;<strong>goes</strong>&nbsp;<strong>against</strong>&nbsp;the&nbsp;<strong>diagnosis</strong>&nbsp;<strong>of</strong>&nbsp;<strong>GBS</strong>.&nbsp;</p>\n<p>The patient is likely to have&nbsp;<strong>clinical worsening during the first four weeks&nbsp;</strong>following the onset of weakness. After this, there's a plateauing of the symptoms and any further deterioration is unlikely.</p>\n<p>The treatment for GBS should be initiated as early as possible. <strong>High-dose intravenous immune globulin (IVIg)</strong> or <strong>plasmapheresis</strong> can be used for the treatment. A <strong>sequential</strong> <strong>combination</strong> of the two has <strong>not</strong> been found to be <strong>more effective</strong> than either of them alone. <strong>Corticosteroids</strong> (option A) are <strong>not effective</strong> in the treatment of GBS.</p><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul><hr><h3>Related Pearl: Mechanism of Immunopathogenesis of Guillain-Barre Syndrome</h3><p>The following sequence of events, takes into consideration, the development of Guillain-Barre syndrome (GBS) associated with <em>Campylobacter jejuni</em><strong> infection</strong>.</p>\n<ol>\n<li><strong>B cells</strong> recognize glycoconjugates on <strong> jejuni (Cj)</strong> that cross-react with <strong>ganglioside</strong> present on <strong>Schwann cell surface</strong> and <strong>subjacent peripheral nerve myelin</strong>.</li>\n<li>Most of the B cells are activated via a partially T cell&ndash;dependent route and secrete primarily <strong>IgG autoantibodies</strong>. Some B cells, activated via a T cell&ndash;independent mechanism, secrete primarily IgM</li>\n<li><strong>The</strong> <strong>activated B cells</strong> escape from Peyer&rsquo;s patches into regional lymph nodes.</li>\n<li><strong>Activated T cells</strong> also function to assist in the opening of the blood-nerve barrier, facilitating penetration of pathogenic autoantibodies.</li>\n<li>The earliest changes in myelin consist of <strong>edema between myelin lamellae</strong> and <strong>vesicular disruption</strong> of the outermost myelin layers.</li>\n<li>These effects are associated with activation of the <strong>C5b-C9 membrane attack complex</strong> and mediated by <strong>calcium entry</strong>; it is possible that the macrophage cytokine tumor necrosis factor (TNF) also participates in <strong>myelin damage</strong>.</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b40cb513616a452c90a928eb9e4fc6d7x1280x1987.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9356",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with abdominal pain and jaundice for the last 5 days. He says that he consumes alcohol occasionally. Which of the following is the likely cause?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Total serum bilirubin </td>\n<td>10 mg/dL</td>\n</tr>\n<tr>\n<td>Serum direct bilirubin</td>\n<td>6 mg/dL</td>\n</tr>\n<tr>\n<td>Serum indirect bilirubin</td>\n<td>4 mg/dL</td>\n</tr>\n<tr>\n<td>Aspartate aminotransferase (AST)</td>\n<td>226</td>\n</tr>\n<tr>\n<td>Alanine aminotransferase (ALT)</td>\n<td>74</td>\n</tr>\n<tr>\n<td>Gamma-glutamyl transferase (GGT)</td>\n<td>75</td>\n</tr>\n<tr>\n<td>Alkaline phosphatase (ALP)</td>\n<td>110</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Alcoholic hepatitis"
        },
        {
          "id": 2,
          "text": "Acute viral hepatitis"
        },
        {
          "id": 3,
          "text": "Gall stones"
        },
        {
          "id": 4,
          "text": "Ischemic hepatitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Both <strong>AST</strong> and <strong>ALT</strong> are <strong>elevated</strong>, and <strong>AST: ALT</strong> <strong>ratio</strong> is <strong>more</strong> than <strong>3:1</strong>. Along with this, there is <strong>elevation of GGT</strong> as well. These findings are likely to be due to <strong>alcoholic hepatitis</strong>.</p>\n<p>Other options:</p>\n<p><strong>Acute viral hepatitis</strong> (option B) and <strong>ischemic hepatitis</strong> (option D) have <strong>markedly</strong> <strong>elevated</strong> <strong>ALT</strong> and <strong>AST</strong>, often <strong>&gt;500 IU</strong>. <strong>ALT</strong> is usually <strong>higher</strong> <strong>than</strong> <strong>AST</strong>. <strong>Gallstones</strong> (option D) can cause <strong>extrahepatic cholestasis</strong>. <strong>ALT</strong> and <strong>AST</strong> are usually <strong>normal</strong> to slightly elevated, but <strong>ALP</strong> is <strong>elevated</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Bilirubin</strong></td>\n<td><strong>AST and ALT</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td><strong>Hemolysis</strong> of RBCs and <strong>Gilbert's syndrome</strong></td>\n<td><strong>Indirect</strong> hyperbilirubinemia</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Acute hepatocellular necrosis, such as in <strong>viral</strong>, <strong>ischemic</strong>, or toxin-induced hepatitis</td>\n<td>Direct and/or indirect hyperbilirubinemia</td>\n<td>\n<p><strong>Elevated, often &gt;500 IU</strong></p>\n<p><strong>Usually ALT&gt;AST</strong></p>\n</td>\n<td>Normal to mildly elevated (less than 3 times normal)</td>\n</tr>\n<tr>\n<td><strong>Alcoholic hepatitis</strong></td>\n<td>Direct and/or indirect hyperbilirubinemia</td>\n<td>\n<p>Elevated</p>\n<p><strong>AST:ALT ratio &gt; 2</strong></p>\n</td>\n<td>Normal to mildly elevated (less than 3 times normal)</td>\n</tr>\n<tr>\n<td><strong>Obstructive jaundice</strong></td>\n<td><strong>Predominantly direct</strong> hyperbilirubinemia</td>\n<td><strong>Normal</strong> to slight elevation</td>\n<td><strong>Elevated, often 4 times the normal value</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Laboratory Evaluation of Liver Disease</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test Category</strong></p>\n</td>\n<td>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte integrity</p>\n</td>\n<td>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biliary excretory function</p>\n</td>\n<td>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum &gamma;-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9345",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman presents with hemoptysis, red-colored urine, and frequent sinusitis. Her blood reports revealed anemia, leucocytosis, and elevated erythrocyte sedimentation rate. Serology is positive for antiproteinase-3 ANCA. Her chest x-ray is given below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Goodpasture's syndrome"
        },
        {
          "id": 2,
          "text": "Microscopic polyangiitis"
        },
        {
          "id": 3,
          "text": "Henoch-Schonlein purpura"
        },
        {
          "id": 4,
          "text": "Granulomatosis with polyangiitis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This patient has the involvement of the&nbsp;<strong>upper respiratory tract</strong>&nbsp;(frequent sinusitis),&nbsp;<strong>lower respiratory tract</strong>&nbsp;(hemoptysis), and&nbsp;<strong>kidneys</strong>&nbsp;(hematuria), and an <strong>x-ray</strong>&nbsp;shows the presence of a&nbsp;<strong>cavity</strong>&nbsp;in the right lung. These, along with laboratory features and positivity for&nbsp;antiproteinase-3 ANCA&nbsp;(cANCA)&nbsp;suggest that the most likely diagnosis is&nbsp;<strong>granulomatosis with polyangiitis </strong>(GPA).</p>\n<p>GPA is a type of vasculitis&nbsp;characterized by <strong>necrotizing granulomas</strong> in the upper and lower respiratory tract, and small and medium vessels. Also, necrotizing crescentic glomerulonephritis is present in the condition.</p>\n<p>Clinically, they present with fever, purulent rhinorrhea, nasal ulcers, sinus pain, saddle nose, polyarthralgia, cough, hemoptysis, breathlessness, hematuria, and proteinuria. Occasionally, cutaneous purpura and mononeuritis complex may be present.</p>\n<p><strong>Antiproteinase 3-ANCA or antineutrophilic cytoplasmic antibody (cANCA)&nbsp;</strong>is seen in 95% of patients and is a useful marker of disease activity.</p>\n<p>Management is as follows:</p>\n<ul>\n<li>Induction with <strong>cyclophosphamide and glucocorticoids</strong> for <strong>severe</strong> disease. This is stopped after 3-6 months and can be switched to rituximab, azathioprine, methotrexate, and mycophenolate mofetil for the remission.</li>\n<li>Induction with <strong>rituximab and glucocorticoids</strong> is also effective in&nbsp;<strong>severe</strong> disease.</li>\n<li>For a <strong>non-severe</strong> disease, <strong>methotrexate or mycophenolate mofetil</strong> along with <strong>glucocorticoids</strong> is effective for induction as well as remission.</li>\n</ul>\n<p>Other options:</p>\n<p>Options A - In&nbsp;<strong>Goodpasture's syndrome </strong>(pulmonary-renal syndrome),<strong> anti-GBM&nbsp;</strong>autoantibodies are formed against the <strong>glomerular basement membrane</strong>. Younger patients present with hemoptysis, fever, dyspnea, and hematuria while older people present with isolated glomerulonephritis.</p>\n<p>Option B - <strong>Microscopic polyangiitis</strong>&nbsp;mainly involves the small arterioles and venules. The presentation is similar to GPA. However, they do not have upper airway disease or pulmonary nodules. They have<strong>&nbsp;mainly MPO antibodies</strong> or<strong> P-ANCA positivity</strong>. The distinction can be made on<strong>&nbsp;</strong>a <strong>biopsy</strong> where microscopic polyangiitis would have vasculitis <strong>without granulomas</strong>.&nbsp;</p>\n<p>Option C - <strong>Henoch-Schonlein purpura</strong> is a small vessel vasculitis that has&nbsp;<strong>palpable purpura</strong> over the buttocks and lower extremities, arthralgia, gastrointestinal symptoms, and glomerulonephritis. It is commonly seen in <strong>children</strong> and the mechanism is immune complex deposition with <strong>IgA antibody.</strong></p><hr><h3>Related Pearl: ANCA Antibodies</h3><p>The antineutrophil cytoplasmic antibodies (<strong>ANCA</strong>) are the antibodies that are targeted against the specific proteins present in <strong>neutrophils</strong> and <strong>monocytes.</strong> They can be further classified as:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Cytoplasmic ANCA (cANCA)</p>\n</td>\n<td>Perinuclear ANCA (pANCA)</td>\n</tr>\n<tr>\n<td>\n<p>Directed against</p>\n</td>\n<td>\n<p>Proteinase 3 (PR3)</p>\n</td>\n<td>Myeloperoxidase (MPO)</td>\n</tr>\n<tr>\n<td>\n<p>Predominantly positive in</p>\n</td>\n<td>\n<p>Granulomatosis with polyangiitis (Wegener granulomatosis)</p>\n</td>\n<td>\n<p>Microscopic polyangiitis</p>\n<p>Churg&ndash;Strauss syndrome&nbsp;</p>\n<p>Crescentic glomerulonephritis</p>\n<p>Inflammatory Bowel Disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Staining pattern</p>\n</td>\n<td>\n<p>Granular cytoplasmic staining</p>\n</td>\n<td>\n<p>Perinuclear or nuclear staining</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Microscopic polyangiitis v/s  granulomatosis with polyangiitis</h3><p>Both microscopic polyangiitis and granulomatosis with polyangiitis are small vessel vasculitides that are mainly caused due to antineutrophil cytoplasmic antibodies (<strong>ANCA). </strong>Therefore, they share common clinical features with some differences.</p>\n<table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>Microscopic polyangiitis</td>\n<td>Granulomatosis with polyangiitis</td>\n</tr>\n<tr>\n<td>Vessels affected</td>\n<td>Small and medium vessel vasculitis</td>\n<td>Small vessel vasculitis</td>\n</tr>\n<tr>\n<td>Principal organs involved</td>\n<td>\n<p>Lungs (hemoptysis)</p>\n<p>Kidney</p>\n<p>GIT</p>\n<p>Skin (cutaneous vasculitis)</p>\n<p>Nerves (Mononeuritis multiplex)</p>\n</td>\n<td>\n<p>Upper respiratory tract</p>\n<p>Lungs (hemoptysis)</p>\n<p>Kidney</p>\n<p>Eye</p>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Upper airway involvement</p>\n</td>\n<td>Less common</td>\n<td>\n<p>More common</p>\n<p>(Sinusitis, otitis media, hearing loss, septal perforation)</p>\n</td>\n</tr>\n<tr>\n<td>Nodular cavities in the lungs</td>\n<td><strong>Absent</strong></td>\n<td><strong>Present</strong></td>\n</tr>\n<tr>\n<td>ANCA</td>\n<td><strong>pANCA (mainly)</strong></td>\n<td><strong>cANCA(mainly)</strong></td>\n</tr>\n<tr>\n<td>Granuloma</td>\n<td><strong>Absent</strong></td>\n<td><strong>Present</strong></td>\n</tr>\n<tr>\n<td>Necrosis</td>\n<td>Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Kidney</td>\n<td>Glomerulonephritis</td>\n<td>Glomerulonephritis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9bc8238b07f247a0b9a757d5ae9c0efa.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9340",
      "difficulty": "medium"
    },
    {
      "text": "A young woman visits a doctor with complaints of joint pain. The doctor observes that she has a rash on her face as shown in the image below. On questioning, she says that the rash pains when she goes under the sun. The doctor advises for the antibody tests and it is found that the patient has high titers of anti-nuclear antibodies, anti-double-stranded DNA antibodies, and anti-ribosomal P antibodies. In addition to the above symptoms, she might also have features of",
      "choices": [
        {
          "id": 1,
          "text": "Depression"
        },
        {
          "id": 2,
          "text": "Autoimmune hemolytic anemia"
        },
        {
          "id": 3,
          "text": "Thrombocytopenia"
        },
        {
          "id": 4,
          "text": "Sicca syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features, rash, and the serology suggest that the patient has <strong>systemic lupus erythematosus.&nbsp;</strong>Since the patient also has high titers of <strong>anti-ribosomal P</strong> antibodies, she might also have features of CNS lupus, like <strong>depression or psychosis.</strong></p>\n<p>Other options</p>\n<p>Option B- Patients may have <strong>autoimmune hemolytic anemia</strong> if they have high titers of <strong>anti erythrocytic antibodies.</strong></p>\n<p>Option C- Patients may have <strong>thrombocytopenia</strong> if they have high titers of <strong>antiplatelet</strong> or <strong>antiphospholipid antibodies</strong></p>\n<p>Option D- Patients may have <strong>sicca syndrome</strong> if they have high titers of <strong>anti-Ro (SSA) antibodies.</strong></p><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Characteristic Findings in Systemic Lupus Erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Characteristic findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blood Vessels</p>\n</td>\n<td>\n<p>Acute necrotizing vasculitis with fibrinoid necrosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p><strong>\"Wire-loop\" lesions</strong></p>\n<p>Tubulointerstitial lesions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Vacuolar degeneration of the basal layer of the epidermis</p>\n<p><strong>Vasculitis with fibrinoid necrosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Joints</p>\n</td>\n<td>\n<p><strong>Non-erosive arthritis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular system</p>\n</td>\n<td>\n<p>Fibrinous pericarditis</p>\n<p><strong>Libman&ndash;Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spleen</p>\n</td>\n<td>\n<p>Splenomegaly</p>\n<p>Capsular thickening</p>\n<p>Follicular hyperplasia</p>\n<p><strong>Onion-skin lesions of arteries</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lungs</p>\n</td>\n<td>\n<p>Pleuritis, pleural effusion, chronic interstitial fibrosis and secondary pulmonary hypertension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone marrow</p>\n</td>\n<td>\n<p><strong>Hematoxylin bodies</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lymph nodes</p>\n</td>\n<td>\n<p>Lymphadenopathy with hyperplastic follicles</p>\n<p>Necrotizing lymphadenitis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>The image below shows</strong>&nbsp;<strong>hematoxylin bodies in systemic lupus erythematosus (SLE)-associated lymphadenopathy.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1da1c0f61e29410c9f97bd2143e58b53x1280x1052.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/318840a064f64ed881b1644ec07401cb.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9306",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man noticed that his shoes no longer fit him, his finger ring is getting tighter, and his jaw seems protruded. The image below compares the size of his hand (right side) with that of the physician (left side). MRI of the brain shows a mass in the pituitary gland. Which of the following is not useful in the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Stereotactic ablation"
        },
        {
          "id": 2,
          "text": "Pegvisomant"
        },
        {
          "id": 3,
          "text": "Oglcegepant"
        },
        {
          "id": 4,
          "text": "Transsphenoidal tumor resection"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical features and the image are suggestive of <strong>acromegaly </strong>which can be managed by<strong> stereotactic ablation,</strong> <strong>pegvisomant and transsphenoidal tumor resection.</strong></p>\n<p>It is commonly caused due to <strong>growth hormone-secreting somatotroph adenoma.</strong> Increased secretion of growth hormone (GH) and insulin-like growth factor- 1 (IGF-1) results in acral bone overgrowth. Patients present with <strong>frontal bossing, increased hand and foot size</strong>, mandibular enlargement with <strong>prognathism</strong>, and widened space between the lower incisor teeth. Soft tissue swelling results in increased heel pad thickness, increased shoe <strong>size, ring tightening</strong>, characteristic coarse facial features, and a <strong>large fleshy nose</strong>.</p>\n<p>Other manifestations seen in GH excess are cardiomyopathy, left ventricular hypertrophy, obstructive sleep apnea, diabetes mellitus, etc.</p>\n<p><strong>Serum IGF-1 levels</strong> and <strong>GH suppression test</strong> with oral <strong>glucose</strong> are useful in the diagnosis. The levels of GH do not reduce in response to the oral glucose load. </p>\n<p>GH-secreting adenomas are managed with <strong>surgery. Transsphenoidal surgical treatment is the preferred surgery. Stereotactic ablation</strong> of GH-secreting <strong>adenomas by gamma-knife radiotherapy</strong> has also been beneficial. Preoperatively, somatostatin analogs like <strong>octreotide</strong> and <strong>lanreotide</strong> are used to shrink the size of the tumor. Another drug that is useful in acromegaly is <strong>pegvisomant</strong>. It is a growth hormone receptor antagonist and, therefore, antagonizes the actions of GH.</p>\n<p>Other options:</p>\n<p>Option C: <strong>Oglcegepant</strong> is a calcitonin gene-related peptide (CGRP) antagonist. It is used for the treatment of migraine.</p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Classification of Pituitary Adenomas with Associated Syndromes</h3><p>The various types of pituitary tumors are listed in decreasing order of frequency:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adenoma cell origin</strong></p>\n</td>\n<td>\n<p><strong>Hormone</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactotroph</p>\n</td>\n<td>\n<p>Prolactin</p>\n</td>\n<td>\n<p>Galactorrhea and amenorrhea (in females)</p>\n<p>Sexual dysfunction, infertility</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gonadotroph</p>\n</td>\n<td>FSH, LH subunits</td>\n<td>\n<p>Hypogonadism, mass effects, and hypopituitarism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Somatotroph&nbsp;</p>\n</td>\n<td>\n<p>GH</p>\n</td>\n<td>\n<p>Gigantism (children)</p>\n<p>Acromegaly (adults)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Corticotroph</p>\n</td>\n<td>ACTH</td>\n<td>\n<p>Cushing's disease</p>\n<p>Nelson's syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mammosomatotroph</p>\n</td>\n<td>\n<p>Prolactin, GH</p>\n</td>\n<td>\n<p>Hypogonadism, galactorrhea, acromegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thyrotroph&nbsp;</p>\n</td>\n<td>\n<p>TSH</p>\n</td>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>GH: Growth hormone</p>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone</p>\n<p>TSH:&nbsp;Thyroid-stimulating hormone</p>\n<p>FSH:&nbsp;Follicle-stimulating hormone</p>\n<p>LH:&nbsp;Luteinizing hormone&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b17bf3edff224c4e837d3b843a743776.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9305",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-old man with no comorbidities presents with altered sensorium, severe headache, and 2 episodes of vomiting. Lumbar puncture reveals an elevated opening pressure and turbid cerebrospinal fluid, which is sent for analysis. Initial results revealed raised neutrophils. What medications should be started until the final reports are available?",
      "choices": [
        {
          "id": 1,
          "text": "Ceftriaxone + vancomycin"
        },
        {
          "id": 2,
          "text": "Ampicillin + ceftriaxone + vancomycin"
        },
        {
          "id": 3,
          "text": "Ampicillin + cefotaxime"
        },
        {
          "id": 4,
          "text": "Ceftriaxone + meropenam"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features <span>suggest <strong>meningitis;</strong></span> given the patient's age and absence of comorbidities, <strong>empirical therapy</strong> with <strong>ceftriaxone</strong> and <strong>vancomycin</strong> should be initiated.</p>\n<p>The patient has elevated intracranial pressure with nuchal rigidity, and <strong>positive Kernig's </strong>(pain on passive extension of the knee when the thigh is flexed on the abdomen)<strong> </strong>and<strong> Brudzinski's </strong>(spontaneous flexion of hips and knees on passive flexion of neck) signs. The cerebrospinal fluid (CSF) appears <strong>turbid</strong>. All these findings are suggestive of bacterial meningitis. The <strong>most common organism</strong> causing bacterial meningitis in adults is <strong>Streptococcus pneumoniae.</strong> Other less common causes are Neisseria meningitidis, Staphylococcus aureus, Listeria monocytogenes, Haemophilus sp., and Enterobacteriaceae, etc.</p>\n<p>Patients may have a fever, headache, nuchal rigidity, and seizures. Signs of meningeal irritation can be elicited by Kernig's and Brudzinki's signs. </p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Cerebrospinal Fluid (CSF) abnormalities in bacterial meningitis</strong></td>\n</tr>\n<tr>\n<td>Opening pressure</td>\n<td>&gt;180 mmH<sub><span class=\"s1\">2</span></sub>O</td>\n</tr>\n<tr>\n<td>White blood cells</td>\n<td>10/μL to 10,000/μL; <strong>neutrophils</strong> predominate</td>\n</tr>\n<tr>\n<td>Red blood cells</td>\n<td>Absent in nontraumatic tap</td>\n</tr>\n<tr>\n<td>CSF/serum glucose</td>\n<td>&lt;0.4</td>\n</tr>\n<tr>\n<td>Protein</td>\n<td> &gt;0.45 g/L (&gt;45 mg/dL)</td>\n</tr>\n<tr>\n<td>Gram’s stain</td>\n<td>Positive in &gt;60%</td>\n</tr>\n<tr>\n<td>Culture</td>\n<td>Positive in &gt;80%</td>\n</tr>\n<tr>\n<td>PCR</td>\n<td>Detects bacterial DNA</td>\n</tr>\n<tr>\n<td><strong>Latex agglutination</strong></td>\n<td>May be positive in patients with meningitis due to Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Escherichia coli, group B streptococci</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p2\">As soon as bacterial meningitis is suspected, <strong>blood cultures</strong> should be <strong>immediately</strong> obtained and the patient should be started on <strong>empirical antibiotics</strong> and <strong>dexamethasone</strong>. </p>\n<p>Choice of empirical antibiotics in various situations is as follows :</p>\n<ul>\n<li class=\"p1\">Preterm infants to infants &lt;1 month - Ampicillin + cefotaxime</li>\n<li class=\"p1\">Infants 1 – 3 months - Ampicillin + cefotaxime or ceftriaxone</li>\n<li class=\"p1\">Immunocompetent children &gt; 3 months and <strong>adults &lt;55 years </strong>- <strong>Cefotaxime, ceftriaxone, or cefepime + vancomycin</strong></li>\n<li class=\"p1\"><strong>Adults &gt; 55 years</strong> and <strong>adults of any age with alcoholism</strong> or other debilitating illnesses - <strong>Ampicillin + cefotaxime, ceftriaxone, or cefepime +vancomycin</strong></li>\n<li class=\"p1\">Hospital-acquired meningitis, posttraumatic or post neurosurgery meningitis, neutropenic patients, or patients with impaired cell-mediated immunity - Ampicillin + ceftazidime or meropenem + vancomycin</li>\n</ul><hr><h3>Related Pearl: Acute bacterial meningitis - causes and empirical treatment</h3><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin+<br />Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><br /></td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><em>L. monocytogenes</em><br />Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin+<br />Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br />Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br />Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state </td>\n<td>\n<p><em> S. pneumoniae                    </em></p>\n<p><em>N. meningitidis                    </em></p>\n<p><em>L. monocytogenes       </em></p>\n<p>Gram negative bacilli </p>\n</td>\n<td>\n<p>Vancomycin+                      Ampicillin+                         Cefepime                           </p>\n<p>                   OR </p>\n<p>Vancomycin+                      Meropenem      </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*PRSP= penicillin-resistant S pneumoniae </p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9303",
      "difficulty": "medium"
    },
    {
      "text": "A 52-year-old female patient was found to have an irregularly irregular heartbeat and absent p waves on an electrocardiogram. She is a known case of hypertension and diabetes mellitus. She does not have a history of congestive heart failure, cerebrovascular or other vascular diseases. What is her CHA2DS2-VASc score?",
      "choices": [
        {
          "id": 1,
          "text": "3"
        },
        {
          "id": 2,
          "text": "4"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario depicts <strong>atrial fibrillation</strong>. The patient is a female (1) and is a known case of diabetes (1) and hypertension (1). Therefore her&nbsp;CHA2DS2-VASc score is<strong> 3.&nbsp;</strong></p>\n<p>The <strong>CHA2DS2-VASc</strong> score is used to assess the <strong>risk of stroke</strong> in patients with <strong>atrial fibrillation. Anticoagulation&nbsp;</strong>is recommended if the score is&nbsp;<strong>&ge;2. </strong>Following risk factors are considered during the calculation of the score:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Congestive heart failure</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Age &ge;75years</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Diabetes mellitus</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Stroke or Transient ischemic attack or embolus</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Vascular disease</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Age 65-75years</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Sex- female</td>\n<td>1&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: CHA2DS2-VASC scoring for risk of stroke  & need for oral anticoagulation in AF</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Components</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C &ndash; Congestive heart failure</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H - Hypertension</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A &ndash; Age &gt; 75 years</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>D &ndash; Diabetes Mellitus</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S &ndash; Stroke/TIA/TE</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">VASc-Vascular disease (prior MI, Peripheral Arterial Disease,</p>\n<p class=\"p1\">or aortic plaque)</p>\n</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;A- Age 65&ndash;74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;S- sex category (i.e., female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>CHADS2 score</strong></p>\n</td>\n<td>\n<p><strong>Antithrombotics </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>Aspirin or no antithrombotics</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Aspirin or oral anticoagulant</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&gt;1</p>\n</td>\n<td>\n<p>Oral anticoagulant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME8505",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man presents with weakness in his right arm and leg for the past 3 hours with a deviation of mouth to the left side. Non-contrast CT is normal. Which of the following medications is not useful in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Oral aspirin"
        },
        {
          "id": 2,
          "text": "Intravenous thrombolysis"
        },
        {
          "id": 3,
          "text": "Tranexamic acid"
        },
        {
          "id": 4,
          "text": "Intravenous mannitol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Sudden onset hemiparesis and facial palsy with apparently normal CT points to ischemic<strong> stroke</strong> in this patient. <strong>Tranexamic acid</strong> is not useful for managing this patient with ischemic stroke as it is an <strong>anti-fibrinolytic agent</strong> used to arrest bleeding and it can cause thromboembolic events. </p>\n<p><strong>Non-contrast CT</strong> is the <strong>imaging modality of choice</strong> in patients with acute stroke. <strong>CT may appear normal</strong> for the first few hours and the infarct may not appear until 24-48 hours. <strong>Diffusion-weighted MRI</strong> is more <strong>sensitive</strong> to detect<strong> early brain infarction</strong>. </p>\n<p>Initial treatment of acute ischemic stroke includes maintaining the patient's airway, breathing, and circulation. Complications such as<strong> hyperglycemia, hypoglycemia,</strong> or<strong> fever </strong>should be treated if present.</p>\n<p>Serum glucose should be maintained between <strong>60 mg/dL</strong> and <strong>180 mg/dL. </strong>Reduction of blood pressure is suggested if &gt;<strong>220/120 mmHg</strong>, presence of malignant hypertension or concomitant <strong>myocardial ischemia</strong>, or if blood pressure is &gt;185/110 mmHg in a patient planned for intravenous thrombolysis.</p>\n<p><strong>Intravenous thrombolysis </strong>with recombinant tissue plasminogen activator (rTPA), <strong>alteplase</strong> (dose 0.9 mg/kg ) should be immediately administered to patients with ischemic stroke who arrive in the window period within<strong> 4.5 hours</strong> of symptom onset. </p>\n<p><strong>Oral aspirin</strong> is recommended for the acute treatment of ischemic stroke.</p>\n<p><strong>IV Mannitol </strong>by raising the serum osmolarity is used to prevent the development of cerebral edema.</p>\n<p><strong>Endovascular mechanical thrombectomy</strong> is done in patients who do not respond to thrombolytic therapy or in whom thrombolysis is contraindicated.</p><hr><h3>Related Pearl: Indications and Contraindications of thrombolysis in Ischemic Stroke</h3><p><strong>Indications for thrombolysis in stroke</strong>&nbsp;</p>\n<ul>\n<li>Clinical diagnosis of stroke</li>\n<li>Onset of symptoms to time of drug administration &lt;3 hours/<strong>4.5</strong> hours</li>\n<li>Age &ge; 18 years</li>\n<li>CT scan showing no haemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory&nbsp;</li>\n</ul>\n<p><strong>Contraindications of thrombolysis in stroke&nbsp;</strong></p>\n<ul>\n<li>Sustained BP &gt;185/110 mmHg despite treatment</li>\n<li>Bleeding diathesis</li>\n<li>Recent head injury or Intracerebral hemorrhage</li>\n<li>Major surgery in preceding 14 days</li>\n<li>Minor stroke symptoms</li>\n<li>Gastrointestinal bleeding in preceding 21 days</li>\n<li>Recent myocardial infarction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9302",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman presents with excruciating pain in her lips, gums, and cheeks for the past 6 months. The pain is usually triggered by talking and brushing her teeth. Each pain episode lasts for 1-2 minutes. On examination, there is no sensory loss over the face. Which of the following is the first-line management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Surgical microvascular decompression"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of<strong> trigeminal neuralgia</strong>.&nbsp;The first-line management of this patient is <strong>carbamazepine.</strong></p>\n<p><strong>Trigeminal&nbsp;</strong>neuralgia is a condition characterized by excruciating paroxysmal pain in the&nbsp;<strong>lips, gums, cheek, </strong>or&nbsp;<strong>chin</strong> and, rarely ophthalmic division of the trigeminal nerve. It is also known as <strong>t</strong><strong>ic douloureux</strong>&nbsp;(a painful condition of the face).&nbsp;It is commonly seen in <strong>middle-aged</strong> and <strong>elderly women</strong>.&nbsp;</p>\n<p>The <strong>large myelinated fibers</strong> of the trigeminal nerve carry<strong> tactile stimuli</strong> from the face and do not carry pain fibers themselves. In trigeminal neuralgia, due to <strong>compression</strong> or other pathologies, the large fibers undergo <strong>demyelination</strong>. These demyelinated large fibers become <strong>hyperexcitable</strong> and&nbsp;<strong>electrically coupled</strong> with the surrounding <strong>smaller unmyelinated pain fibers</strong>&nbsp;of the trigeminal nerve. This explains why <strong>tactile stimulation of trigger zones</strong> (lips, gums, cheek, or chin)&nbsp;<strong>leads to pain</strong> paroxysms. Symptoms occur due to ectopic generation of action potentials in pain-sensitive afferent fibers of the trigeminal nerve root just before entering the pons.</p>\n<p>The pain may occur spontaneously or after movements like <strong>chewing, speaking, smiling, </strong>washing the face, brushing teeth, or exposure to wind. On examination, the physician will <strong>not find</strong> any <strong>sensory loss over</strong> the area. The pain usually lasts for <strong>seconds</strong> or <strong>minutes</strong>. The intensity of pain is&nbsp;severe, so much so that the patient winces. Therefore it is called a&nbsp;'<strong>tic</strong>'.</p>\n<p><strong>Carbamazepine</strong>&nbsp;is the<strong>&nbsp;</strong>first-line drug in the management of patients with trigeminal neuralgia. Lamotrigine, Phenytoin, Topiramate, or Gabapentin are other options that may be tried if Carbamazepine is ineffective. <strong>Microvascular decompression</strong> of the trigeminal nerve can be done if medical therapies fail.</p>\n<p>Differential diagnoses of trigeminal neuralgia include:</p>\n<ul>\n<li><strong>Migraine</strong> and <strong>cluster headaches</strong> - They tend to have <strong>deep-seated</strong> and <strong>continuous</strong> pain while trigeminal neuralgia has more of a superficial stabbing quality pain and is episodic.&nbsp;</li>\n<li><strong>Short-lasting unilateral headache with conjunctival tearing (SUNCT)</strong> - It will typically present with <strong>unilateral conjunctival congestion, tearing,</strong> and nasal stuffiness.&nbsp;</li>\n<li><strong>Temporal arteritis</strong> - It will usually be accompanied by <strong>myalgias</strong> and signs of systemic inflammation. <strong>ESR</strong> and <strong>CRP</strong> will be elevated.</li>\n<li>If trigeminal neuralgia develops in a <strong>young patient</strong> or is <strong>bilateral</strong>, a diagnosis of <strong>multiple sclerosis</strong> should be considered. In such cases, the cause of the pain is a demyelinating plaque near the entry point of the trigeminal nerve in the pons.&nbsp;</li>\n</ul><hr><h3>Related Pearl: Trigeminal Autonomic Cephalalgia</h3><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9293",
      "difficulty": "easy"
    },
    {
      "text": "The reagent used in the pathergy test is",
      "choices": [
        {
          "id": 1,
          "text": "Killed  Bartonella henselae"
        },
        {
          "id": 2,
          "text": "Metabisulphite"
        },
        {
          "id": 3,
          "text": "Normal saline"
        },
        {
          "id": 4,
          "text": "Purified protein derivative"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The reagent used in the pathergy test is <strong>normal saline.</strong></p>\n<p><strong>Pathergy test&nbsp;</strong>is the nonspecific skin inflammatory reaction to <strong>intradermal saline injection.&nbsp;</strong>This test is positive in <strong>Behcet disease.&nbsp;</strong></p>\n<p>The diagnostic criterion in Behcet's syndrome is the presence of <strong>recurrent oral ulcerations</strong> <strong>plus two</strong> of the following:</p>\n<ul>\n<li>Recurrent genital ulceration</li>\n<li>Ocular lesions</li>\n<li>Skin lesions</li>\n<li>Positive pathergy test</li>\n</ul>\n<p>Other options:</p>\n<p>Option A- Intradermal injection of <strong>killed Bartonella henselae</strong> is done in the&nbsp;<strong>Foshay test.</strong> It is positive in <strong>cat scratch disease.</strong></p>\n<p>Option B- <strong>Metabisulphite</strong> is used as a food preservative. It is thought to trigger <strong>asthma.</strong></p>\n<p>Option C- <strong>Purified protein derivative&nbsp;</strong>of mycobacterium is used in the <strong>tuberculin test.</strong>&nbsp;One tuberculin unit is injected intradermally on the flexor aspect of the forearm and a reading is taken after 48h (Mantoux method).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9476",
      "difficulty": "medium"
    },
    {
      "text": "A patient with alcoholic liver disease is found to have the following findings. What is the Child-Turcotte-Pugh (CTP) class in this patient?<div class='question-desc-html'><p>Serum bilirubin- 3.2mg/dL</p>\n<p>Serum albumin- 2.9 mg/dL</p>\n<p>Encephalopathy- Minimal</p>\n<p class=\"p1\">Prothrombin time - increased by 7 s</p>\n<p class=\"p1\">Ultrasound abdomen shows minimal ascitis.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Class A"
        },
        {
          "id": 2,
          "text": "Class C"
        },
        {
          "id": 3,
          "text": "Class D"
        },
        {
          "id": 4,
          "text": "Class B"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The Child-Turcotte-Pugh class for the patient described is <strong>Class C</strong>.</p>\n<p>The points for serum bilirubin 3.2 mg/dl - <strong>3</strong>&nbsp;</p>\n<p>The points for serum albumin 2.9 g/dl - <strong>2&nbsp;</strong></p>\n<p>The points for prothrombin time, increase of more than 6 s - <strong>3</strong>&nbsp;</p>\n<p>The point for minimal ascites -&nbsp;<strong>2&nbsp;</strong></p>\n<p>The points for minimal encephalopathy -&nbsp;<strong>2</strong></p>\n<p>Therefore the Child-Turcotte-Pugh class for the total points (3+2+3+2+2)= <strong>12</strong>&nbsp;is <strong>Class C</strong></p><hr><h3>Related Pearl: Child-Turcotte-Pugh Score</h3><p>The Child&ndash;Turcotte&ndash;Pugh (CTP) score was originally developed to <strong>evaluate the risk of portocaval shunt procedures </strong>performed for<strong> portal hypertension.</strong>&nbsp;It is also useful in predicting the surgical risks of other intra-abdominal operations performed in cirrhotic patients.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>1 Point</strong></p>\n</td>\n<td>\n<p><strong>2 Points</strong></p>\n</td>\n<td>\n<p><strong>3 Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bilirubin level</p>\n</td>\n<td>\n<p>&lt;2 mg/dL</p>\n</td>\n<td>\n<p>2&ndash;3 mg/dL</p>\n</td>\n<td>\n<p>&gt;3 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albumin level</p>\n</td>\n<td>\n<p>&gt;3.5 g/dL</p>\n</td>\n<td>\n<p>2.8&ndash;3.5 g/dL</p>\n</td>\n<td>\n<p>&lt;2.8 g/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin time (increased seconds)</p>\n<p>International normalized ratio</p>\n</td>\n<td>\n<p>1&ndash;3</p>\n<p>&lt;1.7</p>\n</td>\n<td>\n<p>4&ndash;6</p>\n<p>1.7&ndash;2.3</p>\n</td>\n<td>\n<p>&gt;6</p>\n<p>&gt;2.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Encephalopathy</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Child-Turcotte-Pugh class and overall surgical mortality rates:</strong></p>\n<ul>\n<li>Class A = 5&ndash;6 points - Well-compensated - 10% mortality</li>\n<li>Class B = 7&ndash;9 points - Decompensated and significant&nbsp; functional compromise - 30% mortality</li>\n<li>Class C = 10&ndash;15 points - Severerly decompensated - 75-80% mortality</li>\n</ul>\n<p><strong>Prognosis of the various CTP classes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>1-year survival rate &nbsp;%</strong></td>\n<td><strong>2-year survival rate %</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>100</td>\n<td>85</td>\n</tr>\n<tr>\n<td>B</td>\n<td>80</td>\n<td>60</td>\n</tr>\n<tr>\n<td>C</td>\n<td>45</td>\n<td>35</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9374",
      "difficulty": "hard"
    },
    {
      "text": "You have been asked to send routine investigations in patients scheduled for liver transplant in the Gastroenterology ward. Which of the following patients would you not consider as recipients of a liver transplant surgery?",
      "choices": [
        {
          "id": 1,
          "text": "Nonalcoholic Steatohepatitis"
        },
        {
          "id": 2,
          "text": "Alcoholic Liver Disease"
        },
        {
          "id": 3,
          "text": "Primary Sclerosing Cholangitis"
        },
        {
          "id": 4,
          "text": "Metastatic hepatocellular carcinoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Metastatic hepatocellular carcinoma (HCC)</strong>&nbsp;is considered a&nbsp;<strong>contraindication</strong> to transplantation because outcome is very poor.</p><hr><h3>Related Pearl: Indications of liver transplantation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adult</strong></p>\n</td>\n<td>\n<p><strong>Children</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-cholestatic (65%)</p>\n<ul>\n<li>Viral hepatitis B and C</li>\n<li>Alcoholic liver cirrhosis</li>\n<li>Cryptogenic</li>\n</ul>\n<p>Cholestatic (14%)</p>\n<ul>\n<li>Primary biliary cirrhosis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n<p>Autoimmune (5%)</p>\n<p>Malignant neoplasm (2%)</p>\n<p>Miscellaneous (14%)</p>\n</td>\n<td>\n<p>Biliary atresia (58%)</p>\n<p>Inborn errors of metabolism (11%)</p>\n<p>Cholestatic (9%)</p>\n<ul>\n<li>Primary sclerosing cholangitis</li>\n<li>Alagille syndrome</li>\n</ul>\n<p>Autoimmune (4%)</p>\n<p>Viral hepatitis (2%)</p>\n<p>Miscellaneous (16%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3900",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old lady presented to the clinic with the lesions shown below. Which of the following is true with respect to this lesion?",
      "choices": [
        {
          "id": 1,
          "text": "Vascular lesions characterised by the tortuous constriction of arterioles"
        },
        {
          "id": 2,
          "text": "Fill from the outer to center on applying and releasing pressure over the lesion"
        },
        {
          "id": 3,
          "text": "Seen in estrogen-deficient states such as emergency pill use and pregnancy"
        },
        {
          "id": 4,
          "text": "Mainly seen in chronic liver disease - especially alcoholic liver disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The lesions shown in the image are <strong>spider naevi</strong> and it is mainly seen in chronic liver disease - especially alcoholic liver disease.</p>\n<p><strong>Spider naevi</strong> (nevus araneus) are vascular lesions characterized by the<strong> tortuous dilatation of arterioles</strong> just underneath the skin. On applying and releasing pressure over the lesion they typically fill from the center outward.</p>\n<p>They are seen in:</p>\n<ul>\n<li><strong>Estrogen excess</strong> states such as pregnancy and OCP use.</li>\n<li><strong>Chronic liver disease</strong> - especially alcoholic liver disease, and</li>\n<li><strong>Thyrotoxicosis</strong></li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/499a52edb15f4b95b25db3aeecd482d0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3779",
      "difficulty": "easy"
    },
    {
      "text": "A patient with Graves' disease presents with the following finding. Which statement regarding this condition is false?",
      "choices": [
        {
          "id": 1,
          "text": "Acropachy is strongly associated with this condition."
        },
        {
          "id": 2,
          "text": "It occurs in more than 50% of patients with Graves' disease."
        },
        {
          "id": 3,
          "text": "It occurs almost always in the presence of moderate or severe form of ophthalmopathy."
        },
        {
          "id": 4,
          "text": "Skin changes can occur after trauma."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario along with the image is suggestive of <strong>thyroid dermopathy.</strong>&nbsp;It occurs in <strong>&lt;5%</strong> of patients with <strong>Graves&rsquo;</strong> <strong>disease. </strong>Thyroid dermopathy&nbsp;is almost always associated with <strong>ophthalmopathy</strong>.</p>\n<p>Thyroid dermopathy is most frequently observed over the <strong>antero</strong><strong>lateral</strong> parts of the <strong>lower leg. </strong>Hence, it is termed&nbsp;<strong>pretibial myxedema.&nbsp;</strong><strong>Skin changes</strong> can occur at other sites, particularly after <strong>trauma</strong>. The typical lesion is a noninflamed, indurated plaque with a deep pink or purple color and <strong>orange peel-textured papules.</strong></p>\n<p>Thyroid <strong>acropachy</strong> refers to a form of <strong>clubbing</strong>&nbsp;rarely observed in Graves&rsquo; disease. It is strongly <strong>associated</strong> with thyroid dermopathy.</p>\n<p>Thyroid dermopathy usually does not need any active treatment, but if necessary, treatment includes topical, high-potency <strong>glucocorticoid ointment</strong> under an occlusive dressing or octreotide can be useful in some cases.</p>\n<p>The following image shows thyroid dermopathy and acropachy:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12274110d5f0483aad85a047442f26f9x720x505.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e457c1b330714277b45f233d1540f036.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6618",
      "difficulty": "medium"
    },
    {
      "text": "A patient has developed confusion and keeps bumping into objects. He can speak fluently. But on examination, he cannot differentiate between fingers and cannot write. He also gets confused with the examiner's right and left sides. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Gerstmann syndrome"
        },
        {
          "id": 2,
          "text": "Anton syndrome"
        },
        {
          "id": 3,
          "text": "Millard Gubler syndrome"
        },
        {
          "id": 4,
          "text": "Dejerine Roussy syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most likely diagnosis for this patient is<strong> Gerstmann syndrome</strong>.&nbsp;It is commonly associated with damage to the <strong>left (dominant) inferior parietal lobule</strong>.</p>\n<p>Gerstmann syndrome consists of:</p>\n<ul>\n<li><strong>Acalculia -&nbsp;</strong>impairment of simple arithmetic</li>\n<li><strong>Dysgraphia -&nbsp;</strong>impaired writing</li>\n<li><strong>Finger anomia -&nbsp;</strong>an inability to name individual fingers&nbsp;</li>\n<li><strong>Right-left confusion -&nbsp;</strong>an inability to tell whether a hand, foot, or arm of the patient or examiner is on the right or left side of the body</li>\n</ul>\n<p>Option B: Anton syndrome also known as <strong>visual anosognosia</strong> occurs due to bilateral infarction in the distal PCAs. It produces cortical blindness and the patients are unaware of the blindness or may even deny it.</p>\n<p>Option C: Millard-Gubler syndrome occurs due to ventral pontine injury. It&nbsp;causes functional loss of the <strong>6<sup>th</sup> and 7<sup>th</sup></strong> cranial nerves and <strong>corticospinal</strong> tract. This presents as diplopia, ipsilateral facial palsy, ipsilateral loss of corneal reflex, contralateral hemiparesis.</p>\n<p>Option D: Dejerine-Roussy syndrome<strong>&nbsp;</strong>is associated with<strong>&nbsp;</strong>hemisensory loss and severe burning pain in the affected region. It is also known as <strong>thalamic pain syndrome.</strong></p><hr><h3>Related Pearl: Stroke syndromes with visual symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Site of lesion</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anton&rsquo;s syndrome</p>\n</td>\n<td>\n<p>B/L infarction in the distal PCAs</p>\n</td>\n<td>\n<p>Cortical blindness, with denial or unawareness of blindness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Balint&rsquo;s syndrome</p>\n</td>\n<td>\n<p>Low flow in the &ldquo;watershed region&rdquo; between distal PCA and MCA territories</p>\n</td>\n<td>\n<p>Palinopsia</p>\n<p>Asimultanagnosia</p>\n<p>Optic ataxia</p>\n<p>Ocular apraxia</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Weber&rsquo;s syndrome</p>\n</td>\n<td>\n<p>Midbrain</p>\n</td>\n<td>\n<p>I/L CN III palsy</p>\n<p>C/L hemiplegia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Parinaud&rsquo;s syndrome</p>\n</td>\n<td>\n<p>Dorsal midbrain</p>\n</td>\n<td>\n<p>Tetrad of symptoms:</p>\n<p>Loss of upgaze</p>\n<p>Light-near dissociation</p>\n<p>Convergence &ndash; retraction nystagmus</p>\n<p>Lid retraction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Benedikt syndrome</p>\n</td>\n<td>\n<p>Midbrain</p>\n</td>\n<td>\n<p>Ipsilateral oculomotor nerve palsy</p>\n<p>Contralateral hemiparesis</p>\n<p>Contralateral cerebellar ataxia</p>\n<p>Holmes tremor</p>\n<p>Choreoathetosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9676",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old male patient presented with pain and swelling in the knee joint. The physician advised for the examination of synovial fluid from the knee joint on polarized light microscopy, which showed needle-shaped crystals. What is the composition and birefringence pattern shown by these crystals?",
      "choices": [
        {
          "id": 1,
          "text": "Calcium apatite with positive birefringence"
        },
        {
          "id": 2,
          "text": "Monosodium urate crystals with negative birefringence"
        },
        {
          "id": 3,
          "text": "Calcium pyrophosphate crystals with negative birefringence"
        },
        {
          "id": 4,
          "text": "Calcium oxalate crystals with positive birefringence"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and the presence of&nbsp;<strong>needle-shaped</strong> crystals in synovial fluid point towards the diagnosis of&nbsp;<strong>gouty arthritis.&nbsp;</strong>It is caused by the deposition of <strong>monosodium urate crystals (MSU</strong>), which are needle-shaped and show <strong>n</strong><strong>egative birefringence</strong>&nbsp;on polarized light microscopy.</p>\n<p>The below image shows&nbsp;<strong>n</strong><strong>egative birefringent&nbsp;</strong>needle-shaped crystals seen in gout.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/82878ae5ce2140a8894a4cced872cf41x889x657.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A-<strong> Calcium apatite</strong> crystals can occur in areas of tissue damage (<strong>dystrophic calcification</strong>) and in hypercalcemic or hyperparathyroid states (<strong>metastatic calcification</strong>).&nbsp;Clumps of these crystals may appear as intra- or extracellular nonbirefringent globules or aggregates that stain purplish with Wright&rsquo;s stain and bright red with alizarin red S.</p>\n<p>Option C- <strong>Calcium pyrophosphate </strong>crystals (rhomboid-shaped) deposition is seen in <strong>pseudogout</strong>. These <strong>crystals</strong>&nbsp;are rod-shaped or rhomboid-shaped and are&nbsp;weakly positive or nonbirefringent crystals.</p>\n<p>Option D<strong>- Calcium oxalate</strong> crystals (CaOx) are seen in <strong>chronic renal failure</strong>.&nbsp;These crystals can be deposited in visceral organs, blood vessels, bones, and joints. The synovial fluid analysis will show the presence of variable-shaped crystals (commonly bipyramidal crystals are seen) with&nbsp;variable birefringence to polarized light.</p>\n<p>NOTE:</p>\n<p>Though pseudogout is the condition in which the knee joint is most commonly involved, gout can also involve the knee joint.</p>\n<p>Below image shows the crystals seen in pseudogout.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/20327f598d9d4e99b6290b6c7fa66bd6x473x426.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Gout and Pseudo-gout</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Gout</strong></p>\n</td>\n<td>\n<p><strong>Pseudogout</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crystal composition</p>\n</td>\n<td>\n<p>Monosodium urate</p>\n</td>\n<td>\n<p>Calcium pyrophosphate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Needle like</p>\n</td>\n<td>\n<p>Rhomboid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Birefringence pattern</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Weak positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most commonly affected joint</p>\n</td>\n<td>\n<p>1<sup>st</sup> MTP</p>\n</td>\n<td>\n<p>Knee</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>X-ray findings</p>\n</td>\n<td>\n<p>Periarticular erosions with overhanging margins</p>\n</td>\n<td>\n<p>Chondrocalcinosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3958",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following increase or decrease appetite:\nA- Leptin\nB- Orexin\nC- Ghrelin",
      "choices": [
        {
          "id": 1,
          "text": "A:↓, B:↓, C:↓"
        },
        {
          "id": 2,
          "text": "A:↑, B:↓, C:↑"
        },
        {
          "id": 3,
          "text": "A:↓, B:↑, C:↑"
        },
        {
          "id": 4,
          "text": "A:↑, B:↑, C:↓"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Leptin decreases</strong> the appetite whereas <strong>Ghrelin</strong> <strong>and Orexin increases</strong> the appetite.</p><hr><h3>Related Pearl: Neurotransmitters and Hormones that influence Feeding and Satiety Centers in the Hypothalamus</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increased Appetite (Orexigenic)</strong></p>\n</td>\n<td>\n<p><strong>Decreased Appetite (Anorexigenic)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Neuropeptide Y</strong></p>\n<p>Agouti-related protein (AGRP)</p>\n<p>Melanin-concentrating hormone (MCH)</p>\n<p><strong>Orexins A and B</strong></p>\n<p>Endorphins</p>\n<p>Galanin</p>\n<p>Amino acids (glutamate and &gamma; aminobutyric acid)</p>\n<p>Cortisol</p>\n<p><strong>Ghrelin</strong></p>\n<p>Growth hormone-releasing hormone (GHRH)</p>\n<p>Endocannabinoids</p>\n</td>\n<td>\n<p><strong>Melanocyte-stimulating hormone</strong> (MSH)</p>\n<p><strong>Leptin</strong></p>\n<p>Serotonin</p>\n<p>Norepinephrine</p>\n<p><strong>Corticotropin-releasing hormone (CRH)</strong></p>\n<p><strong>Insulin</strong></p>\n<p><strong>Cholecystokinin (CCK)</strong></p>\n<p>Glucagon-like peptide</p>\n<p><strong>Cocaine-and amphetamine-regulated transcript (CART)</strong></p>\n<p>Bombesin</p>\n<p>Peptide YY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3955",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old woman with a history of multiple sclerosis comes to the hospital. She complains of blurring of vision in one of the eyes soon after she comes home after her zumba classes. What is the name of this sign?",
      "choices": [
        {
          "id": 1,
          "text": "Lhermitte’s sign"
        },
        {
          "id": 2,
          "text": "Uhthoff’s phenomenon"
        },
        {
          "id": 3,
          "text": "Myokymia"
        },
        {
          "id": 4,
          "text": "Tic douloureux"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>The blurring</strong> of vision after a <strong>physical exercise</strong> in multiple sclerosis is <strong>Uhthoff's Phenomenon</strong>. </p>\n<p><strong>Uhthoff ’s phenomenon</strong> refers to the <strong>unilateral visual blurring</strong> that may occur during a <strong>hot shower</strong> or with<strong> physical exercise</strong>. It is an exacerbation of the symptoms of multiple sclerosis due to heat.</p>\n<p>Other options:</p>\n<p>Option A:<strong> Lhermitte's sign </strong>is an electric <strong>shock-like sensation</strong> radiating down the back into the legs. It is induced typically by flexion or other movements of the neck. Lhermitte’s sign can also occur simultaneously with other disorders of the cervical spinal cord like cervical spondylosis.</p>\n<div class=\"page\" title=\"Page 3581\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 3580\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option C: <strong>Facial myokymia</strong> is a persistent, rapid flickering contraction of the facial musculature or a contraction that slowly spreads across the face. It results from lesions of the corticobulbar tracts or in the course of the facial nerve in the brainstem.</p>\n<p>Option D: <strong>Tic douloureux </strong>is the other name for trigeminal neuralgia. It can occur when the demyelinating lesion involves the root entry (or exit) of the fifth cranial nerve.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3809",
      "difficulty": "easy"
    },
    {
      "text": "The clinical triad of pheochromocytoma includes all of the following symptoms except:",
      "choices": [
        {
          "id": 1,
          "text": "Headache"
        },
        {
          "id": 2,
          "text": "Hypertension"
        },
        {
          "id": 3,
          "text": "Profuse sweating"
        },
        {
          "id": 4,
          "text": "Palpitation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical<strong> triad</strong> of <strong>pheochromocytoma</strong> includes the following&nbsp;<strong>symptoms</strong>:</p>\n<ul>\n<li>Headache</li>\n<li>Profuse sweating</li>\n<li>Palpitation (due to tachycardia)</li>\n</ul>\n<p>Hypertension is the most predominant<strong> sign</strong> of pheochromocytoma. Though <strong>intermittent</strong> <strong>hypertension</strong> is a classical feature, sustained hypertension is also common.</p><hr><h3>Related Pearl: Clinical features of Pheochromocytoma (By frequency of occurrence)</h3><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches &ndash; most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) &ndash; most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3159",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old male who is a known case of ulcerative colitis presents with exacerbation of symptoms. His stool frequency suddenly increased to 10-12 times in the past 24 hours, with blood in stools. Investigations revealed a CRP of 60 mg/L. Which of the following is used to define the severity of this disease?",
      "choices": [
        {
          "id": 1,
          "text": "Truelove–Witts criteria"
        },
        {
          "id": 2,
          "text": "McDonald’s criteria"
        },
        {
          "id": 3,
          "text": "Montreal classification"
        },
        {
          "id": 4,
          "text": "King's College Hospital Criteria"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given clinical scenario, the patient presented with <strong>acute severe ulcerative colitis</strong>. <strong>Truelove-Witts criteria</strong> is used to define acute severe colitis.</p>\n<p>Truelove-Witts criteria define acute severe colitis as the presence of:</p>\n<ol>\n<li><strong>≥ 6 bloody stools/24 hrs</strong></li>\n<li>Plus, one or more of the following features suggestive of systemic toxicity:\n<ul>\n<li>Anemia (Hemoglobin &lt;10 g/dL).</li>\n<li>Mild fever (&gt;100.04°F)<strong>.</strong></li>\n<li>Tachycardia (Pulse ≥90 beats/min).</li>\n<li>High inflammatory markers (ESR &gt; 30 mm/hr <strong>or</strong> CRP &gt;30 mg/L).</li>\n</ul>\n</li>\n</ol>\n<p>Other options :</p>\n<p>Option B: The 2017 <strong>revised McDonald’s criteria</strong> is used in the diagnosis of <strong>multiple sclerosis. </strong>It takes into consideration the clinical attacks and objective lesions. In addition, it also involves the assessment of the lesions based on MRI and other imaging techniques.</p>\n<p>Option C: The <strong>Montreal classification </strong>is<strong> </strong>used for classifying <strong>Crohn's disease</strong>.</p>\n<p>Option D:<strong> The King's College Hospital Criteria</strong> is a prognostic tool for patients with acute liver failure (ALF).</p><hr><h3>Related Pearl: Inflammatory Bowel Disease (IBD)</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset </strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades </td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td> None </td>\n<td>\n<p>Smoking </p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life </p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1 </td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement </p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps </p>\n<p>Backwash ileitis </p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings </strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia  </p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications </strong></td>\n<td>\n<p>Fistulas </p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings </strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis </p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7186",
      "difficulty": "medium"
    },
    {
      "text": "A 56-year-old diabetic male patient complains of a burning sensation in both legs and episodes of excruciating pain, tingling, and a sensation he describes as \"pins and needles.\" Which of the following drugs is used in the first-line treatment for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Valproate"
        },
        {
          "id": 3,
          "text": "Duloxetine"
        },
        {
          "id": 4,
          "text": "Venlafaxine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, the patient has&nbsp;<strong>painful diabetic neuropathy</strong>.<strong> Duloxetine</strong>&nbsp;is a selective serotonin&ndash;norepinephrine reuptake inhibitor (<strong>SSNRI</strong>) and is one of the drugs used in the first-line treatment of painful diabetic neuropathy.<strong>&nbsp;</strong></p>\n<p>Painful diabetic neuropathy&nbsp;manifests as a burning, excruciating, stabbing, or intractable type of&nbsp;pain&nbsp;or presents with tingling or numbness. The pathophysiology of this condition is due to primarily metabolic and vascular factors.</p>\n<p>Treatment of painful sensory neuropathies:</p>\n<p>&nbsp;<strong>First line</strong>:</p>\n<ul>\n<li>Lidoderm 5% patch</li>\n<li>Tricyclic antidepressants (e.g., amitriptyline, nortriptyline)</li>\n<li>Gabapentin, Pregabalin</li>\n<li><strong>Duloxetine</strong></li>\n</ul>\n<p><strong>Second line</strong>:</p>\n<ul>\n<li><strong>Carbamazepine</strong></li>\n<li>Phenytoin</li>\n<li><strong>Venlafaxine</strong></li>\n<li>Tramadol</li>\n</ul>\n<p>Third line:</p>\n<ul>\n<li>Mexiletine</li>\n</ul><p>Optimal glucose control is considered the cornerstone for the treatment of diabetes and its complications. Intensive glucose control has been shown to prevent the development of peripheral neuropathy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7084",
      "difficulty": "medium"
    },
    {
      "text": "A 51-year-old female is undergoing a clinical assessment for aphasia. Her speech is non-fluent and interrupted by many word-finding pauses. She says, \"walk dog\", and nods her head when asked if she meant to say, \"I want to take the dog for a walk\". The comprehension of speech is intact, and the patient knows what she wants to say. Other neurological examination findings are within normal limits. Which area of brain damage can result in such a type of aphasia?",
      "choices": [
        {
          "id": 1,
          "text": "Inferior frontal gyrus of the dominant hemisphere"
        },
        {
          "id": 2,
          "text": "Posterior temporal and parietal lobes, dominant hemisphere"
        },
        {
          "id": 3,
          "text": "Posterior parietal and temporal lobes, non-dominant hemisphere"
        },
        {
          "id": 4,
          "text": "Superior surface of the superior temporal gyrus, dominant hemisphere"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The patient described above has <strong>Broca’s aphasia</strong> (WA). This usually occurs as a result of vascular damage to <strong>Broca's motor speech area </strong>in the <strong>inferior frontal gyrus </strong>due to occlusion of the <strong>superior </strong>division of the<strong> middle cerebral artery (MCA).</strong></p>\n<p>A lesion in this region leads to motor/Broca's aphasia. Speech is <strong>non-fluent</strong> and interrupted by many word-finding pauses. The speech is impoverished in function words that contribute to the syntax but is enriched in meaningful nouns and verbs. However, comprehension of speech is intact, and the patient knows what he wants to say.</p>\n<p>For example, a patient with Broca's aphasia may say, \"walk dog\" instead of \"I want to take the dog for a walk\". Speech therapy in Broca's aphasia is more successful than in Wernicke’s aphasia.</p>\n<p>Aphasia is an acquired <strong>disorder of language</strong> due to damage to the brain. It occurs either secondary to brain injury or degeneration and involves the left cerebral hemisphere to a greater extent. Both written and spoken communication are affected. Audio-visual understanding is also deranged.</p>\n<p>There is difficulty in finding words, leading to poorly understood content for the listener. These patients also find it difficult to repeat sentences and name things properly. Aphasia is diagnosed in patients with deficits in the formal aspects of language, such as word-finding, word choice, comprehension, spelling, or grammar.</p>\n<p>Many specific aphasic syndromes have been reported. The most common are <strong>Broca, Wernicke, conduction</strong>, and <strong>global</strong> aphasias. Other are non-peri-sylvian aphasias that include anomic, transcortical motor, transcortical sensory, and mixed transcortical, sometimes called the isolation of the speech area syndrome.</p>\n<p><strong>Wernicke’s aphasia</strong> occurs as a result of damage in the posterior temporal and parietal regions, which are supplied by the lower division of the <strong>middle cerebral artery</strong>.</p><hr><h3>Related Pearl: Aphasias and Related Conditions</h3><table><colgroup><col span=\"5\" /> </colgroup>\n<tbody>\n<tr>\n<td class=\"xl63\">&nbsp;</td>\n<td class=\"xl65\"><strong>Comprehension</strong></td>\n<td class=\"xl65\"><strong>Repetition of Spoken language</strong></td>\n<td class=\"xl65\"><strong>Naming</strong></td>\n<td class=\"xl65\"><strong>Fluency</strong></td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Wernicke's</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Broca's</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Decreased</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Global</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Decreased</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Conduction</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Anterior (nonfluent) transcortical</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Posterior (fluent) transcortical</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Isolation</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Echolalia</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">No purposeful speech</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Anomic</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved except for word finding pauses</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Pure Word Deafness</strong></td>\n<td class=\"xl64\">Impaired only for spoken language</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Pure Alexia</strong></td>\n<td class=\"xl64\">Impaired only for reading</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved&nbsp;</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c1cb9177ba6f447ead67de336cd40692x1280x1590.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Brodmann areas</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/985d9f9c21e142b787a38323bc997372x600x535.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1c16e1eaa21a41bf97b6cbe2769e08f8x600x487.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Area of the Brain(Brodmann)</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td><strong>3, 1</strong> and <strong>2</strong> -&nbsp;Primary sensory area</td>\n<td>\n<p>Postcentral gyrus</p>\n<p>Extends to the posterior part of the paracentral lobule medially</p>\n</td>\n</tr>\n<tr>\n<td><strong>4</strong> -&nbsp;Primary motor area</td>\n<td>\n<p>Precentral gyrus</p>\n<p>Extends to the anterior part of the paracentral lobule medially</p>\n</td>\n</tr>\n<tr>\n<td><strong>6</strong>-&nbsp;Premotor area</td>\n<td>\n<p>Anterior to Area 4</p>\n<p>In the posterior parts of superior, middle and inferior frontal gyri</p>\n</td>\n</tr>\n<tr>\n<td><strong>5</strong> and <strong>7</strong> -&nbsp;Sensory association area</td>\n<td>Superior parietal lobule</td>\n</tr>\n<tr>\n<td><strong>8</strong> -&nbsp;Frontal eye field</td>\n<td>Posterior part of middle frontal gyrus, anterior to the facial area of the precentral gyrus</td>\n</tr>\n<tr>\n<td><strong>44</strong> and&nbsp;<strong>45</strong> -&nbsp;Broca&rsquo;s(Motor speech) area</td>\n<td>Inferior frontal gyrus of the dominant hemisphere</td>\n</tr>\n<tr>\n<td>\n<p><strong>41</strong> and <strong>42</strong> -&nbsp;</p>\n<p>Primary auditory area</p>\n</td>\n<td>Superior surface of the superior temporal gyrus(Heschl&rsquo;s gyrus)</td>\n</tr>\n<tr>\n<td><strong>22</strong>* -&nbsp;Wernicke&rsquo;s(Sensory speech) area</td>\n<td>Superior temporal gyrus</td>\n</tr>\n<tr>\n<td><strong>17</strong> -&nbsp;Primary visual(striate) area</td>\n<td>Walls and floor of the posterior part of calcarine sulcus (postcalcarine sulcus) in the occipital lobe</td>\n</tr>\n<tr>\n<td>\n<p><strong>18</strong> and&nbsp;<strong>19</strong>-&nbsp;</p>\n<p>Visual association area</p>\n</td>\n<td>Remaining part of the medial and superolateral surfaces of the occipital lobe</td>\n</tr>\n<tr>\n<td><strong>28</strong> -&nbsp;Primary olfactory area</td>\n<td>Anterior part of the parahippocampal gyrus and uncus</td>\n</tr>\n<tr>\n<td><strong>43</strong> -&nbsp;Gustatory(taste) area</td>\n<td>Inferior part of the parietal lobe, posterior to the general sensory area of the mouth</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*There is uncertainty about the extent of the Wernicke's area. Some authorities consider areas 39 and 40 as part of Wernicke's area in addition to area 22.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7138",
      "difficulty": "medium"
    },
    {
      "text": "A young man presents with recurrent, excruciating, and stabbing type of left-sided headaches. He has been experiencing at least 1 episode every other day. It typically lasts for  an hour and occurs around the same time everyday. Examination reveals nasal congestion and a watery left eye. Which of the following can be given to manage this acute episode?",
      "choices": [
        {
          "id": 1,
          "text": "Verapamil"
        },
        {
          "id": 2,
          "text": "100% O2 at 10 -12 L/min"
        },
        {
          "id": 3,
          "text": "Lorazepam"
        },
        {
          "id": 4,
          "text": "Indomethacin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A patient with repetitive brief <strong>unilateral,</strong> excruciating stabbing <strong>headaches, </strong>occurring almost at the <strong>same time everyday</strong>,&nbsp;associated with<strong> lacrimation</strong> and <strong>rhinorrhea</strong> most probably has a diagnosis of&nbsp;<strong>cluster headache.</strong>&nbsp;The acute episodes in this condition can be&nbsp;treated with<strong>&nbsp;100% O<sub>2</sub>&nbsp;</strong>at <strong>10 -12 L/min.&nbsp;</strong></p>\n<p><strong>High flow oxygen</strong> is crucial in the management of an acute attack. The duration of oxygen therapy should last&nbsp;<strong>15</strong>&nbsp;to<strong> 20 minutes.&nbsp;</strong>Other treatment options for an acute attack of cluster headache include injectable/nasal form of&nbsp;<strong>sumatriptan</strong><strong>.&nbsp;</strong>Noninvasive vagus nerve stimulation (nVNS) is also approved by the FDA for the treatment of acute episodes of cluster headaches.</p>\n<p>Cluster headache is a form of primary headache characterized by excruciating recurrent headache, that is unilateral in nature, and typically lasting between <strong>15 </strong>to<strong> 180 minutes</strong>. The important feature of this headache is&nbsp;<strong>periodicity</strong>. At least one of the daily attacks of pain recurs at the same hour each day.&nbsp;</p>\n<p>It also causes severe,&nbsp;<strong>unilateral retroorbital pain</strong>&nbsp;with&nbsp;<strong>autonomic features</strong>, such as <strong>unilateral lacrimation</strong>,<strong> nasal congestion</strong>, and <strong>conjunctival injection</strong>. Occasionally features of Horner's syndrome may be seen.&nbsp; Patients with cluster headaches are&nbsp;more often smokers with a higher than average alcohol consumption.</p>\n<p>The drugs used in the <strong>prophylaxis</strong> of cluster headaches are <strong>verapamil </strong>(<strong>most common</strong>), topiramate, gabapentin, etc.</p>\n<p>Other options:</p>\n<p>Option A. <strong>Verapamil</strong> is the drug of choice for the <strong>prophylaxis</strong> of cluster headaches.</p>\n<p>Option C. Lorazepam does not have a role&nbsp;in the management of cluster headaches.</p>\n<p>Option D. <strong>Indomethacin</strong> is used in the management of <strong>paroxysmal hemicrania</strong>. This condition is characterized by unilateral severe headaches lasting between 2 to 45 minutes and can occur more than 5 times a day. Unlike cluster headache, paroxysmal hemicrania has a very good response to indomethacin.&nbsp;</p><hr><h3>Related Pearl: Trigeminal Autonomic Cephalalgia</h3><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7140",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true about Friedreich's ataxia?",
      "choices": [
        {
          "id": 1,
          "text": "Skin lesions represent a common manifestation of this disorder"
        },
        {
          "id": 2,
          "text": "The molecular defect involves the expansion of a trinucleotide repeat sequence"
        },
        {
          "id": 3,
          "text": "The onset of symptoms occurs after age 25 years"
        },
        {
          "id": 4,
          "text": "It is transmitted in an autosomal dominant manner"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Friedreich's ataxia (FA)</strong>&nbsp;is a rare genetic disease that occurs due to spinocerebellar degeneration. It is inherited as an autosomal recessive disorder due to a molecular defect on&nbsp;<strong>chromosome 9</strong>&nbsp;that involves a <strong>GAA trinucleotide repeat</strong> <strong>expansion</strong>.</p>\n<p>It is the most common of the&nbsp;<strong>autosomal recessive</strong>&nbsp;ataxias. There is a loss of large myelinated axons in peripheral nerves, though the unmyelinated fibers in sensory roots and peripheral sensory nerves are spared.</p>\n<p>It results in difficulty in walking, loss of sensation in the upper and lower limbs, and impairment of speech. The patients develop ataxia usually before the age of 25 years. Other features include:</p>\n<ul>\n<li>Progressive dysarthria</li>\n<li>Bilateral extensor plantar responses</li>\n<li>Sensory polyneuropathy with absent deep tendon reflexes in the lower extremities.</li>\n<li>Scoliosis and pes cavus</li>\n</ul>\n<p>The patients may also develop certain ECG abnormalities such as like supraventricular tachyarrhythmias secondary to cardiac involvement. Diabetes mellitus is more common and this syndrome is associated with an increased incidence of cancer.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6541",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged man complains of the frequent dropping of handheld things and tripping while walking. On examination, the patient appeared as shown in the image below. Strength is 4/5 in the intrinsic muscles of the hand. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Duchenne muscular dystrophy"
        },
        {
          "id": 2,
          "text": "Becker muscular dystrophy"
        },
        {
          "id": 3,
          "text": "Myotonic dystrophy"
        },
        {
          "id": 4,
          "text": "Pompe disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span data-preserver-spaces=\"true\">The above clinical scenario and the image showing the patient with <strong>frontal balding,</strong> and a typical </span><strong><span data-preserver-spaces=\"true\">hatchet-faced appearance</span></strong> <span data-preserver-spaces=\"true\">are suggestive </span><span data-preserver-spaces=\"true\">of&nbsp;</span><strong><span data-preserver-spaces=\"true\">type 1 myotonic</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">dystrophy</span></strong><span data-preserver-spaces=\"true\">.</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Myotonic dystrophy</span></strong><span data-preserver-spaces=\"true\">&nbsp;is an <strong>autosomal dominant</strong> disorder. It is caused due to <strong>CTG trinucleotide repeat</strong> in DMPK gene on chromosome 19. It is mainly of two types: myotonic dystrophy<strong> type 1</strong> (DM1), and myotonic dystrophy<strong> type 2</strong> (DM2).</span></p>\n<p><span data-preserver-spaces=\"true\">Clinically, patients will have a typical </span><strong><span data-preserver-spaces=\"true\">hatchet-faced appearance</span></strong><span data-preserver-spaces=\"true\">&nbsp;due to wasting of the temporal and masseter muscles. Frontal baldness and a high-arched palate are also seen.&nbsp;</span></p>\n<p><span data-preserver-spaces=\"true\">It is associated with weakness in the&nbsp;</span><strong><span data-preserver-spaces=\"true\">distal muscles</span></strong><span data-preserver-spaces=\"true\">&nbsp;of the wrist, fingers, and foot. </span><span data-preserver-spaces=\"true\">Involvement of the&nbsp;</span><strong><span data-preserver-spaces=\"true\">palatal, pharyngeal,</span></strong><span data-preserver-spaces=\"true\">&nbsp;and&nbsp;</span><strong><span data-preserver-spaces=\"true\">tongue</span></strong><span data-preserver-spaces=\"true\">&nbsp;muscles causes&nbsp;</span><strong><span data-preserver-spaces=\"true\">dysarthria</span></strong><span data-preserver-spaces=\"true\">&nbsp;and&nbsp;</span><strong><span data-preserver-spaces=\"true\">dysphagia.&nbsp;</span></strong><span data-preserver-spaces=\"true\">Involvement of&nbsp;<strong>the diaphragm</strong>&nbsp;and&nbsp;<strong>intercostal muscles&nbsp;</strong>leads to respiratory insufficiency. <strong>Proximal muscles</strong> remain <strong>unaffected.</strong><br /></span></p>\n<p><span data-preserver-spaces=\"true\">Diagnosis is mainly clinical. ECG shows conduction abnormalities in the form of first-degree heart block. </span><span data-preserver-spaces=\"true\">Electromyography may show myotonia in DM1, however, it is patchy in DM2. Creatine kinase levels in the serum may be normal or mildly elevated.</span></p>\n<p><span data-preserver-spaces=\"true\">The histopathological finding of muscle biopsy in both DM1, and DM2, shows internalized nuclei seen in individual muscle fibers, and the presence of several atrophic fibers with pyknotic nuclear clumps.</span></p>\n<p><span data-preserver-spaces=\"true\">Treatment is mainly symptomatic. However, <strong>mexiletine</strong> is indicated for both DM1 and DM2 help in reducing myotonia.</span></p>\n<p>Other options:</p>\n<p>Options A and B:<strong><span data-preserver-spaces=\"true\"> Duchenne </span></strong>and<strong><span data-preserver-spaces=\"true\"> Becker&nbsp;</span></strong><span data-preserver-spaces=\"true\">muscular dystrophies present with <strong>proximal muscle weakness.</strong> These are <strong>x-linked recessive</strong> dystrophies. Therefore, family history would reveal that mainly&nbsp;<strong>men</strong> in the family are affected.</span></p>\n<p><span data-preserver-spaces=\"true\">Option D: In&nbsp;</span><strong><span data-preserver-spaces=\"true\">Pompe's disease</span></strong><span data-preserver-spaces=\"true\">&nbsp;or acid maltase deficiency is a glycogen storage disease. Affected children present with hypotonia, myocardiopathy, and hepatosplenomegaly. Respiratory muscle weakness leading to <strong>ventilatory insufficiency</strong> may be a prominent feature.</span></p><hr><h3>Related Pearl: Location of Important Genes on Chromosome</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Gene</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P73</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Folate transporter</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">21q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Neuroblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Rhodopsin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>VHL</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ADPKD-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">4q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>APC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MHC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ARPKD</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Cystic fibrosis</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>RET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">10</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>WT-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">11p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>vWF</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">12</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Retinoblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA_1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin -1</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">15</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin-2</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P53</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Dystrophin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Xp21.2</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">22q</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f6145d55d16c4202ab5102eb43fd30c8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6279",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old female was diagnosed with a large pituitary mass on MRI scanning. The presence of high circulating levels of which of the following hormones avoids the need for surgical resection of the pituitary gland?",
      "choices": [
        {
          "id": 1,
          "text": "Growth hormone"
        },
        {
          "id": 2,
          "text": "Luteinizing hormone"
        },
        {
          "id": 3,
          "text": "Prolactin"
        },
        {
          "id": 4,
          "text": "Adrenocorticotropic hormone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Circulating prolactin levels should always be assessed in cases of pituitary adenomas, as the presence of <strong>high prolactin levels</strong> indicates <strong>prolactinoma</strong>, which can be treated with <strong>dopamine agonists</strong>, thereby avoiding unnecessary surgical resection.</p>\n<p><strong>Dopamine agonists</strong> are <strong>first-line therapy</strong> in most patients with prolactinoma. Commonly used dopamine agonists include bromocriptine, cabergoline, and quinagolide.</p>\n<p>Dopamine agonists <strong>reduce serum prolactin concentration</strong> and cause a significant reduction in the tumor size after several months of therapy. If the patient has any <strong>visual defects</strong> due to tumor suppression effects, they tend to i<strong>mprove within a few days</strong> after the administration of dopamine agonists.</p>\n<p>Prolonged use of <strong>ergot-derived dopamine agonists</strong> such as <strong>bromocriptine</strong> and <strong>cabergoline</strong> may cause fibrotic reactions in the heart due to interaction with 5-HT<sub>2B</sub> receptors. These effects are mostly seen in patients with <strong>Parkinson's disease.</strong> Hence, if prolonged treatment is required, then non-ergot agents such as <strong>quinagolide</strong> are indicated.</p>\n<p>In patients who achieve normoprolactinemia and significant reduction of the tumor mass, the dopamine agonist can be withdrawn after two years of therapy.</p>\n<p>Note that surgical decompression is usually necessary only when a macroprolactinoma does not respond adequately to dopamine agonist therapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6262",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old woman presents with headache, fatigue, malar rash, and arthralgia. Her blood pressure is 180/100 mmHg. Urinalysis revealed hematuria, proteinuria (4 g/dL), and RBC casts. She has high titers of anti-dsDNA antibodies. A renal biopsy was done, and light microscopy showed sub-endothelial deposits, resembling wire-loop lesions. Findings of immunofluorescence staining are shown below. Which of the following is the most appropriate next step in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Hemodialysis and maintenance therapy with azathioprine"
        },
        {
          "id": 2,
          "text": "Therapeutic plasma exchange and high-dose steroids"
        },
        {
          "id": 3,
          "text": "Low-dose steroids and azathioprine for 3-6 months"
        },
        {
          "id": 4,
          "text": "High-dose steroids and mycophenolate mofetil for 2-6 months"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span data-preserver-spaces=\"true\">The clinical features and investigation findings are diagnostic of&nbsp;</span><strong><span data-preserver-spaces=\"true\">lupus nephritis.</span></strong><span data-preserver-spaces=\"true\">&nbsp;The image shows a characteristic&nbsp;</span><strong><span data-preserver-spaces=\"true\">full-house pattern</span></strong><span data-preserver-spaces=\"true\">&nbsp;of positive staining for <strong>all immune reactants</strong>. The next best step in the management is to induce remission by administering&nbsp;</span><strong><span data-preserver-spaces=\"true\">high-dose steroids</span></strong><span data-preserver-spaces=\"true\">, in combination with&nbsp;</span><strong><span data-preserver-spaces=\"true\">mycophenolate</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">mofetil</span></strong><span data-preserver-spaces=\"true\">&nbsp;or&nbsp;</span><strong><span data-preserver-spaces=\"true\">cyclophosphamide&nbsp;</span></strong><span data-preserver-spaces=\"true\">for 2-6 months.&nbsp;</span></p>\n<p>This is followed by <strong>maintenance therapy</strong> with lower doses of steroids and mycophenolate mofetil or azathioprine.&nbsp;<span data-preserver-spaces=\"true\">(Option C)</span></p>\n<p><span data-preserver-spaces=\"true\">Evaluating the clinical case given in the question:</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">The presence of&nbsp;</span><strong><span data-preserver-spaces=\"true\">malar</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">rash</span></strong><span data-preserver-spaces=\"true\">&nbsp;and&nbsp;</span><strong><span data-preserver-spaces=\"true\">arthralgia</span></strong><span data-preserver-spaces=\"true\">&nbsp;is suggestive of systemic lupus erythematosus (</span><strong><span data-preserver-spaces=\"true\">SLE</span></strong><span data-preserver-spaces=\"true\">).</span></li>\n<li><span data-preserver-spaces=\"true\">Urinalysis shows&nbsp;</span><strong><span data-preserver-spaces=\"true\">hematuria</span></strong><span data-preserver-spaces=\"true\">&nbsp;(&gt;5 RBCs/HPF), and&nbsp;</span><strong><span data-preserver-spaces=\"true\">nephrotic range proteinuria</span></strong><span data-preserver-spaces=\"true\">&nbsp;(&gt;3.5 g/dL),&nbsp;</span><strong><span data-preserver-spaces=\"true\">RBC</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">casts.&nbsp;</span></strong><span data-preserver-spaces=\"true\">These findings, along with the presence of high titers of&nbsp;</span><strong><span data-preserver-spaces=\"true\">anti-dsDNA antibodies,</span></strong><span data-preserver-spaces=\"true\">&nbsp;are indicative of&nbsp;</span><strong><span data-preserver-spaces=\"true\">lupus nephritis.</span></strong></li>\n<li><span data-preserver-spaces=\"true\">Light microscopic examination of the renal biopsy revealed characteristic&nbsp;</span><strong><span data-preserver-spaces=\"true\">'wire-loop' lesion</span></strong><span data-preserver-spaces=\"true\">s, which are seen due to sub-endothelial immune complex deposition. The presence of wire-loop lesions is suggestive of&nbsp;</span><strong><span data-preserver-spaces=\"true\">diffuse proliferative lupus nephritis (class IV).</span></strong></li>\n<li><span data-preserver-spaces=\"true\">Further, immunofluorescence staining, as shown in the image, revealed positive staining for all immune reactants (IgG, IgA, IgM, C1q, C3, kappa, and lambda light chain), commonly known as the \"</span><strong><span data-preserver-spaces=\"true\">full-house</span></strong><span data-preserver-spaces=\"true\">\"&nbsp;</span><strong><span data-preserver-spaces=\"true\">effect,</span></strong><span data-preserver-spaces=\"true\">&nbsp;characteristic of lupus nephritis.</span></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/83937613e5c54891a6a12b3730fa0801x777x583.JPEG\" alt=\"Explanation Image\"><p><strong>Lupus nephritis:</strong></p>\n<p>Lupus nephritis is a serious complication of <strong>SLE </strong>and is&nbsp;seen in about 30-50% of patients with the disease. Renal involvement may be in the form of <strong>glomerulonephritis</strong> or <strong>tubulointerstitial</strong> <strong>nephritis</strong>. Glomerular lesions develop due to the deposition of the circulating immune complexes on the glomerular basement membrane, mesangium, and/or throughout the glomerulus.</p>\n<p>Depending on the biopsy findings, lupus nephritis is <strong>classified into six classes.</strong> The details of the classification by the international society of nephrology are provided in the pearl attached below.&nbsp;</p>\n<p>Therapeutic plasma exchange (Option B):</p>\n<ul>\n<li>It is indicated in patients with severe lupus nephritis who do not respond to conventional therapy.</li>\n<li>It is also indicated in patients with lupus nephritis who present with <strong>anti-phospholipid antibody syndrome.</strong></li>\n</ul>\n<p>20% of patients with lupus nephritis will reach end-stage disease and may require <strong>dialysis</strong>&nbsp;(Option A) or transplantation.&nbsp;</p><hr><h3>Related Pearl: Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Class&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal mesangial lupus nephritis (class I)</p>\n</td>\n<td>\n<p><strong>Immune complex deposition</strong> in&nbsp;the mesangium without structural changes by light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mesangial proliferative lupus nephritis (class II)</p>\n</td>\n<td>\n<p><strong>Mesangial cell proliferation</strong> with mesangial immune deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal lupus nephritis (class III)</p>\n</td>\n<td>\n<p>Focal, segmental <strong>glomerulonephritis</strong> involving <strong>less than 50%</strong> of all glomeruli.</p>\n<p>Focal subendothelial deposits with or without mesangial changes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse lupus nephritis (class IV)</p>\n</td>\n<td>\n<p>The most common and severe form of lupus nephritis</p>\n<p>Diffuse&nbsp;<strong>glomerulonephritis</strong> involving <strong>more than 50%</strong> of all glomeruli</p>\n<p>Diffuse subendothelial deposits with or without mesangial changes<strong>. &ldquo;Wire loop&rdquo;</strong> structures on light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous lupus nephritis (class V)</p>\n</td>\n<td>\n<p>Global or segmental&nbsp;<strong>subepithelial</strong> immune deposits with or without mesangial proliferation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Advanced sclerosing lupus nephritis (class VI)</p>\n</td>\n<td>\n<p><strong>Sclerosis</strong> of <strong>more than 90%</strong> of the glomeruli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Focal- Involves only a few glomeruli</li>\n<li>Diffuse- Involves almost all the glomeruli</li>\n<li>Segmental- Involves only a part of glomerulus</li>\n<li>Global- Involves entire glomerulus</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b83e16725c9e4acbae2e0ff8275ec1a5x1279x911.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7a6e343aa0d941ddbb5efaa3da087fee.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6175",
      "difficulty": "medium"
    },
    {
      "text": "A 42-year-old man presents with acidity and abdominal pain for the past few months, not relieved by taking antacids. Endoscopy revealed prominent gastric folds and ulcers on the second part of the duodenum. Investigations revealed elevated serum gastrin levels and increased basal acid secretion. Which of the following is the next best investigation?",
      "choices": [
        {
          "id": 1,
          "text": "Endoscopic ultrasound guided deep gastric biopsy"
        },
        {
          "id": 2,
          "text": "Blood gastrin levels following secretin administration"
        },
        {
          "id": 3,
          "text": "Monoclonal antibody-based H. pylori stool antigen test"
        },
        {
          "id": 4,
          "text": "Double contrast barium study of proximal  GI tract"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of peptic ulcers and poor response to antacids, together with elevated serum gastrin levels and increased basal acid secretion are suggestive of<strong> Zollinger-Ellison syndrome.</strong> The next best investigation to confirm the diagnosis is to perform a <strong>secretin stimulation test.</strong></p>\n<p>In normal individuals, the administration of secretin causes no change or a slight decrease in blood gastrin levels. However, in patients with ZE syndrome, the circulating <strong>gastrin levels paradoxically increase</strong> following <strong>secretin</strong> administration.</p>\n<p><strong>Other investigations</strong> include:</p>\n<ul>\n<li>Tumor localization and staging using a combination of CT and endoscopic ultrasound</li>\n<li>Radio-labeled somatostatin receptor scintigraphy</li>\n<li><sup>68</sup>gallium DOTATATE PET scanning</li>\n</ul>\n<p><strong>Other options:</strong></p>\n<p>Option A:<strong> </strong>Endoscopic ultrasound-guided deep <strong>gastric biopsy</strong> is usually done to diagnose infiltrating gastric tumours such as linitis plastica (GLP) and gastric lymphoma.</p>\n<p>Options C and D: <strong>Monoclonal antibody-based H pylori stool antigen test and double-contrast barium study </strong>of proximal GI tract are the tests indicated for the diagnostic evaluation of H. pylori peptic ulcer disease.</p><hr><h3>Related Pearl: Diagnostic tests in Zollinger Ellison Syndrome</h3><p>To confirm the diagnosis of ZES,</p>\n<ul>\n<li><strong>Gastric pH &lt;2.5</strong> and</li>\n<li><strong>Serum gastrin &gt;1000pg/ml</strong> (normal &lt;100pg/ml)</li>\n</ul>\n<p>Provocative tests can be done like the <strong>secretin stimulation test</strong> when the diagnosis is in doubt. An <strong>increase in serum gastrin &gt;200pg/ml</strong> following an IV bolus of secretin (2U/kg) is diagnostic.</p>\n<p>Other tests:</p>\n<ul>\n<li><strong>BAO &gt;15mEq/h</strong> (or &gt;5mEq/h if they have had a procedure for peptic ulcer)</li>\n<li><strong>BAO: MAO ratio </strong>is <strong>increased </strong>(<strong>&gt;0.6</strong>)</li>\n</ul>\n<p>(BAO=Basal acid output; MAO=Maximal acid output)</p>\n<p>For localization</p>\n<ul>\n<li>Initial investigation - CT or MRI</li>\n<li>Best investigation - <strong>Endoscopic ultrasound</strong></li>\n<li>If the tumor is not localized - <strong>Somatostatin receptor scintigraphy</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6244",
      "difficulty": "medium"
    },
    {
      "text": "A 78-year-old male was diagnosed with clostridium difficile infection due to a prolonged course of antibiotics for intraabdominal infection following a ruptured diverticular abscess. He was treated with metronidazole, and diarrhea resolved. After 2-weeks he developed loose, non-bloody stools about six times a day. Stool toxin assay was done, which was again positive for C difficile. He was treated with vancomycin for 10 days with a resolution. 10 days later, he presented with relapsed C difficile infection. Which of the following is the next best step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Metronidazole 500 mg 3 times daily for 7-10 days"
        },
        {
          "id": 2,
          "text": "Vancomycin 125 mg 4 times daily for 7-10 days"
        },
        {
          "id": 3,
          "text": "Intravenous immunoglobulin"
        },
        {
          "id": 4,
          "text": "Fecal microbiota transplantation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span data-preserver-spaces=\"true\">This is a case of&nbsp;</span><strong><span data-preserver-spaces=\"true\">recurrent clostridium difficile</span></strong><span data-preserver-spaces=\"true\">&nbsp;infection, for which&nbsp;</span><strong><span data-preserver-spaces=\"true\">Fecal microbiota transplantation (FMT)</span></strong><span data-preserver-spaces=\"true\">&nbsp;is recommended. The procedure involves transplantation of stool from a healthy donor, into the patient with the disease by enema or colonoscopy. FMT is increasingly being used to restore a more advantageous gut microbiome profile.</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Clostridium difficile infection:</span></strong></p>\n<p><span data-preserver-spaces=\"true\">It is the most common antibiotic-associated diarrhea. It is commonly seen in individuals who receive a prolonged antibiotic course, which causes a change in the composition of gastrointestinal microbial flora, leading to colonization of C. difficile.</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Clinical features:</span></strong></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">The majority of the cases (&gt;80%) occur in patients above 65 years of age with comorbidities.</span></li>\n<li><span data-preserver-spaces=\"true\">The onset is insidious and may occur within 1 - 6 weeks after the initiation of antibiotic treatment.</span></li>\n<li><span data-preserver-spaces=\"true\">The symptoms include lower abdominal pain with loose watery diarrhea.</span></li>\n<li><span data-preserver-spaces=\"true\">In some patients, the disease may progress to life-threatening pseudomembranous colitis.</span></li>\n</ul>\n<p><strong><span data-preserver-spaces=\"true\">Investigations</span></strong><span data-preserver-spaces=\"true\">:</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Detection of clostridium</span><strong><span data-preserver-spaces=\"true\">&nbsp;toxins A or B</span></strong><span data-preserver-spaces=\"true\">&nbsp;in the stool.</span></li>\n<li><span data-preserver-spaces=\"true\">Stool screening is initially done for the detection of glutamate dehydrogenase enzyme (</span><strong><span data-preserver-spaces=\"true\">GDH</span></strong><span data-preserver-spaces=\"true\">) produced by C. difficile or&nbsp;</span><strong><span data-preserver-spaces=\"true\">PCR</span></strong><span data-preserver-spaces=\"true\">&nbsp;to detect C. difficile nucleic acid. If the screening is positive,&nbsp;</span><strong><span data-preserver-spaces=\"true\">C. difficile toxin ELISA</span></strong><span data-preserver-spaces=\"true\">&nbsp;or&nbsp;</span><strong><span data-preserver-spaces=\"true\">tissue</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">culture</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">cytotoxicity</span></strong><span data-preserver-spaces=\"true\">&nbsp;is usually performed.</span></li>\n<li><span data-preserver-spaces=\"true\">Sigmoidoscopy reveals characteristic appearance, with&nbsp;</span><strong><span data-preserver-spaces=\"true\">erythema, white plaques</span></strong><span data-preserver-spaces=\"true\">, or an&nbsp;</span><strong><span data-preserver-spaces=\"true\">adherent pseudomembrane.</span></strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4fa6bda728204ae6a3aaa5a045ba11dfx524x456.JPEG\" alt=\"Explanation Image\"><p><strong>Management:</strong></p>\n<ul>\n<li>If the patient is currently prescribed any antibiotics, they should be stopped, and the patient should be isolated.</li>\n<li><strong>First-line therapy</strong>&nbsp;includes immediate cessation of the offending antibiotic along with a 10-day course of oral <strong>fidaxomicin</strong> for mild cases. Oral vancomycin can also be used, but oral fidaxomicin is preferred as it has a lesser relapse rate.</li>\n<li>Intravenous immunoglobulin and or glucocorticoids may be administered in patients with most severe disease or those who are unresponsive to the initial therapy.</li>\n<li>In cases of recurrent C. difficile infection, <strong>fecal microbiota transplantation (FMT)&nbsp;</strong>is usually done, which helps in restoring the gut microbiome profile.</li>\n</ul><hr><h3>Related Pearl: Diagnostic criteria for Clostridium difficile infection</h3><p>&nbsp;</p>\n<p>The diagnosis of CDI is based on a combination of clinical criteria:</p>\n<p>1.Diarrhea (&ge;3 unformed stools per 24 h for &ge;2 days) with no other recognized cause&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2.Detection of toxins A or B in the stool by PCR or culture</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p>&nbsp;Detection of pseudomembranes in the colon</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6257",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following tumors is not associated with syndrome of inappropriate ADH secretion (SIADH)?",
      "choices": [
        {
          "id": 1,
          "text": "Ewing’s sarcoma"
        },
        {
          "id": 2,
          "text": "Thymoma"
        },
        {
          "id": 3,
          "text": "Chromophobe adenoma"
        },
        {
          "id": 4,
          "text": "Carcinoid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Chromophobe adenoma is a type of pituitary adenoma that causes symptoms of hypogonadism due to pressure effects on the pituitary stalk. It is not a cause of syndrome of inappropriate ADH secretion (SIADH).</p><hr><h3>Related Pearl: Causes of SIADH</h3><p><strong>Neoplasms</strong></p>\n<p><strong>Carcinomas</strong></p>\n<ul>\n<li>Lung</li>\n<li>Duodenum</li>\n<li>Pancreas</li>\n<li>Ovary</li>\n<li>Bladder, ureter</li>\n</ul>\n<p><strong>Other neoplasms</strong></p>\n<ul>\n<li>Thymoma</li>\n<li>Mesothelioma</li>\n<li>Bronchial adenoma</li>\n<li>Carcinoid</li>\n<li>Gangliocytoma</li>\n<li>Ewing&rsquo;s sarcoma</li>\n</ul>\n<p><strong>Head trauma</strong> (closed and penetrating)</p>\n<p><strong>Infections</strong></p>\n<ul>\n<li>Pneumonia</li>\n<li>Abscess</li>\n<li>Cavitation (aspergillosis)</li>\n<li>Tuberculosis</li>\n<li>Meningitis, Encephalitis</li>\n<li>AIDS</li>\n</ul>\n<p><strong>Vascular</strong></p>\n<ul>\n<li>Cerebrovascular occlusions, haemorrhage</li>\n<li>Cavernous sinus thrombosis</li>\n</ul>\n<p><strong>Neurologic</strong></p>\n<ul>\n<li>Guillain-Barre syndrome</li>\n<li>Multiple sclerosis</li>\n<li>Delirium tremens</li>\n<li>Amyotrophic lateral sclerosis</li>\n<li>Hydrocephalus</li>\n<li>Psychosis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Congenital malformations</strong></p>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Acute intermittent porphyria</li>\n</ul>\n<p><strong>Respiratory</strong></p>\n<ul>\n<li>Asthma</li>\n<li>Pneumothorax</li>\n<li>Positive-pressure respiration</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>Vasopressin or desmopressin</li>\n<li>Serotonin reuptake inhibitors</li>\n<li>Oxytocin (high dose)</li>\n<li>Vincristine</li>\n<li>Carbamazepine</li>\n<li>Nicotine</li>\n<li>Phenothiazines</li>\n<li>Cyclophosphamide</li>\n<li>Tricyclic antidepressants</li>\n<li>Monoamine oxidase inhibitors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6761",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist received a blood-tinged CSF sample for evaluation. The sample was subjected to centrifugation and the following finding was observed. What is the least likely differential diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Traumatic tap"
        },
        {
          "id": 2,
          "text": "Subarachnoid hemorrhage"
        },
        {
          "id": 3,
          "text": "Liver disease"
        },
        {
          "id": 4,
          "text": "Elevated protein levels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows <strong>xanthochromatic CSF</strong> on centrifugation. This is unlikely with a traumatic tap. A traumatic tap has clear supernatant following CSF centrifugation.</p>\n<p>Xanthochromia refers to the yellowish appearance of CSF. In a lumbar puncture, a traumatic tap can be confused with subarachnoid hemorrhage (SAH) as both show blood in the drawn CSF sample. In such situations, <strong>centrifugation</strong> of the sample distinguishes the two.</p>\n<ul>\n<li><strong>Clear supernatant</strong> following CSF centrifugation supports a&nbsp;<strong>traumatic tap</strong>.</li>\n<li><strong>Xanthochromatic</strong> supernatant suggests <strong>SAH</strong>.</li>\n</ul>\n<p>Xanthochromatic supernatant may be present in the following conditions:</p>\n<ul>\n<li>In <strong>Liver disease,</strong>&nbsp;due to elevated bilirubin levels.</li>\n<li>When <strong>CSF protein</strong> concentration is <strong>elevated.</strong></li>\n<li>In subarachnoid hemorrhage (<strong>SAH</strong>), RBCs are present in the CSF long enough for them to undergo lysis. This releases hemoglobin which is converted to bilirubin, thus staining the CSF yellow.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d2c9d467b91449539d691a616a9692e3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9594",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is true regarding plasma calcium?",
      "choices": [
        {
          "id": 1,
          "text": "Ca2+ sensing receptor is a voltage gated ion channel"
        },
        {
          "id": 2,
          "text": "Albumin bound calcium is physiologically most important"
        },
        {
          "id": 3,
          "text": "Calcium is mainly absorbed from large intestine"
        },
        {
          "id": 4,
          "text": "Acidosis favours ionization of calcium"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">Acidosis favors the ionization of calcium.</p>\n<p class=\"p1\">Clinical correlation:&nbsp;</p>\n<p class=\"p1\">Hyperventilation by causing alkalosis favors the deionization of calcium without reducing the total calcium levels. Thus, alkalosis can precipitate tetany and laryngospasm in calcium-deficient patients</p>\n<p class=\"p1\">The ca2+ sensing receptor is a type of <strong>G protein-coupled receptor</strong> (GPCR).&nbsp;50% of the Ca2+ is in <strong>ionized form</strong> and is physiologically most important.&nbsp;Calcium is mainly absorbed from the&nbsp;<strong>small intestine</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0946",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old man presents with acute pain in the chest which radiates to the interscapular region of the back. He is a known hypertensive for the past 10 years. His CT is shown below. Which of the following drug is contraindicated in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Hydralazine"
        },
        {
          "id": 2,
          "text": "Esmolol"
        },
        {
          "id": 3,
          "text": "Labetalol"
        },
        {
          "id": 4,
          "text": "Verapamil"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and the CT image showing double-lumen of the aorta are suggestive of <strong>aortic dissection</strong>. Isolated use of a direct vasodilator such as<strong> hydralazine</strong> is contraindicated in acute dissection.</p>\n<p>It is because these agents can increase <strong>hydraulic shear</strong> and <strong>worsen the dissection&nbsp;</strong>by causing vasodilation without&nbsp;reducing the left ventricular ejection force that continues to weaken the arterial wall.&nbsp;</p>\n<p>Medical therapy for aortic dissection includes <strong>beta-blockers</strong>&nbsp;and<strong> sodium nitroprusside </strong>to reduce cardiac contractility and blood pressure. The heart rate is reduced to around 60 bpm and the SBP is lowered to <span class=\"Y0NH2b CLPzrc\">&le;</span> 120mmHg.</p>\n<p>CCBs like verapamil and diltiazem may be used IV if nitroprusside or beta-blockers cannot be employed.&nbsp;Parenteral <strong>angiotensin-converting enzyme </strong>(ACE) <strong>inhibitor</strong> such as enalaprilat may be considered.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/04f3c05f113a44a3bf566233aa1b45c2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7159",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common pattern of thyroid hormone levels in a patient with sick euthyroid syndrome?<div class='question-desc-html'><ol>\n<li>Decreased T3, Normal T4, Normal TSH</li>\n<li>Decreased T3 , Decreased T4, Normal TSH</li>\n<li>Normal T3, Normal T4, Increased TSH</li>\n<li>Normal T3, Increased T4, Normal TSH</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common hormone pattern observed in <strong>sick euthyroid syndrome</strong> (SES) is a&nbsp;decrease in total and unbound T3 levels with normal levels of T4 and TSH. This pattern is&nbsp;called&nbsp;<strong>low T3 syndrome.</strong></p>\n<p>SES is caused by an acute severe illness in the absence of underlying thyroid disease. T4 to T3 conversion via <strong>peripheral deiodination </strong>is<strong> impaired&nbsp;</strong>leading to a fall in T3 corresponding to the severity of illness.&nbsp;There is an adaptive <strong>increase</strong> in the level of<strong> reverse T3</strong> (rT3).&nbsp;</p>\n<p>In very sick patients, there can be a dramatic fall in both total T4 and T3 levels. This pattern is called <strong>low T4 syndrome</strong> and&nbsp;is associated with a <strong>poor prognosis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6626",
      "difficulty": "medium"
    },
    {
      "text": "What are the key cytokines involved in the pathogenesis of ankylosing spondylitis?",
      "choices": [
        {
          "id": 1,
          "text": "Interferon γ & IL-23"
        },
        {
          "id": 2,
          "text": "Interferon γ & IL-17"
        },
        {
          "id": 3,
          "text": "TNF-α & IL-13"
        },
        {
          "id": 4,
          "text": "TNF-α & IL-17"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The key cytokines involved in the pathogenesis of <strong>ankylosing spondylitis</strong>&nbsp;are&nbsp;<strong>TNF-&alpha;</strong>&nbsp;and<strong> IL-17. </strong>IL-23 also plays a role in pathogenesis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1210",
      "difficulty": "medium"
    },
    {
      "text": "Management of hyperkalaemia includes all except",
      "choices": [
        {
          "id": 1,
          "text": "Calcium gluconate"
        },
        {
          "id": 2,
          "text": "Insulin drip"
        },
        {
          "id": 3,
          "text": "Salbutamol nebulisation"
        },
        {
          "id": 4,
          "text": "Magnesium sulphate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, <strong>magnesium sulphate</strong> has <strong>no role</strong> in the management of <strong>hyperkalemia</strong>.</p>\n<p>Hyperkalemia is a <strong>medical emergency</strong> that requires urgent treatment. Even in the <strong>absence of ECG changes</strong>, patients with <strong>plasma K+ concentration &ge;6.5 mEq/L&nbsp;</strong>should be aggressively managed.</p>\n<p><strong>Intravenous calcium gluconate</strong> (10 mL of 10% solution) is administered over 2-3 minutes with cardiac monitoring to protect the heart while other measures are taken to correct hyperkalemia. Calcium <strong>increases</strong> the <strong>threshold of action potential</strong> thereby <strong>reducing excitability</strong>.&nbsp;</p>\n<p><strong>Insulin-dextrose infusion</strong> is given to <strong>shift potassium into cells</strong>. The recommended dose is 10 units of regular insulin followed immediately by 50 mL of 50% dextrose. &beta;2-agonists like <strong>salbutamol</strong> can also be used in conjunction with insulin.</p>\n<p><strong>Cation exchange resins</strong>, <strong>diuretics</strong>, and <strong>dialysis</strong> are used to <strong>eliminate potassium</strong>. Sodium polystyrene sulfonate is a cation exchange resin that exchanges sodium for potassium in the gastrointestinal tract, increasing fecal excretion of potassium. Newer intestinal potassium binders like <strong>patiromer</strong> and ZS-9 are preferred due to their lack of intestinal toxicity. <strong>Hemodialysis</strong> is the <strong>most effective</strong> method to <strong>reduce plasma potassium concentration</strong>.</p>\n<p>In hypovolemic patients with oliguria, intravenous saline may be beneficial to improve distal delivery of sodium and enhancing renal potassium excretion. Loop and thiazide diuretics can be used in hypervolemic patients with sufficient renal function.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9281",
      "difficulty": "easy"
    }
  ]
}